HADM_ID,ICUSTAY_ID,CHARTTIME,CATEGORY,DESCRIPTION,TEXT,Summary
151778.0,205979,2150-01-12 06:33:00,Physician ,Physician Resident Progress Note,"Chief Complaint:
   24 Hour Events:
   repeat EKG w/less TWF in V3-4, but persists in [**4-2**]
   -Cardiac enzymes CK 13, Trop 0.02
   -Repeat hct 20 (after IVF) but ordered1U prbcs (all cell lines down)
   but partially diluated; 23 this AM prior to transfusion
   - spoke with ID, cont new regimen (dapto/[**Last Name (un) **]/po vanco) until blood
   cultures/ c. diff return, then consider switching back or getting ID
   consult.
   - holding valgancyclovir given pancytopenia. Will await CMV VL and
   consider restarting.
   - CBC pancytopenia improving. Still with 6% bands
   - Renal Recs: Dialysis tuesday, hold valcyte pending CMV VL.
   - hemolysis labs negative
   - AM labs pancytopenia, pt placed on neutropenic precautions.
   Allergies:
   Bactrim Ds (Oral) (Sulfamethoxazole/Trimethoprim)
   Exfoliative [**Doctor Last Name **]
   Cellcept (Oral) (Mycophenolate Mofetil)
   Rash;
   Zosyn (Intraven) (Piperacillin Sodium/Tazobactam)
   Myelosuppressio
   Last dose of Antibiotics:
   Daptomycin - [**2150-1-11**] 04:19 AM
   Meropenem - [**2150-1-12**] 12:18 AM
   Vancomycin - [**2150-1-12**] 12:18 AM
   Infusions:
   Other ICU medications:
   Omeprazole (Prilosec) - [**2150-1-11**] 08:46 AM
   Coumadin (Warfarin) - [**2150-1-11**] 04:00 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2150-1-12**] 06:20 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**51**] AM
   Tmax: 36.9
C (98.5
   Tcurrent: 36.7
C (98
   HR: 79 (73 - 95) bpm
   BP: 109/72(81) {88/45(56) - 123/82(90)} mmHg
   RR: 20 (18 - 27) insp/min
   SpO2: 99%
   Heart rhythm: SR (Sinus Rhythm)
             Total In:
                                                                  2,765 mL
                                                                    163 mL
   PO:
                                                                  1,100 mL
             TF:
   IVF:
                                                                  1,290 mL
                                                                    163 mL
   Blood products:
                                                                    375 mL
   Total out:
                                                                    100 mL
                                                                      0 mL
   Urine:
                                                                    100 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  2,665 mL
                                                                    163 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 99%
   ABG: ///22/
   Physical Examination
   GENERAL: Ill appearing female
   HEENT: PERRL, O/P Clear, mucous membranes dry
   NECK: No lymphadenopathy, Left tunneled HD line in place, minimal
   erythema, no tenderness
   CARDIAC:  RRR no murmurs
   LUNG:  Clear bilaterally, no wheezing or rhonchi
   ABDOMEN:  Soft, NT, ND, +BS, palpated kidney on right lower quadrant
   EXT:  No clubbing, edema, warm and well pefused, 2+ DP/PT pulses
   bilatearlly
   NEURO:  Alert and oriented x3
   Labs / Radiology
   76 K/uL
   7.8 g/dL
   77 mg/dL
   4.2 mg/dL
   22 mEq/L
   3.6 mEq/L
   15 mg/dL
   107 mEq/L
   140 mEq/L
   25.3 %
   2.3 K/uL
        [image002.jpg]
                             [**2150-1-10**]  11:24 PM
                             [**2150-1-11**]  05:41 AM
                             [**2150-1-11**]  03:29 PM
                             [**2150-1-12**]  05:03 AM
   WBC
   2.9
   2.8
   3.5
   2.3
   Hct
   20.6
   23.1
   27.4
   25.3
   Plt
   65
   60
   96
   76
   Cr
   3.0
   3.1
   4.2
   TropT
   0.02
   0.02
   Glucose
   119
   74
   77
   Other labs: PT / PTT / INR:30.4/30.4/3.0, CK / CKMB /
   Troponin-T:17//0.02, Alk Phos / T Bili:/0.4, Differential-Neuts:26.0 %,
   Band:4.0 %, Lymph:62.0 %, Mono:5.0 %, Eos:2.0 %, Lactic Acid:1.4
   mmol/L, LDH:443 IU/L, Ca++:8.6 mg/dL, Mg++:2.0 mg/dL, PO4:2.8 mg/dL
   Assessment and Plan
 ANEMIA, CHRONIC
 DEEP VENOUS THROMBOSIS (DVT), UPPER EXTREMITY
 SEPSIS WITHOUT ORGAN DYSFUNCTION
 RENAL FAILURE, END STAGE (END STAGE RENAL DISEASE, ESRD)
 SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)
   52 year old female with ESRD on HD, recent VRE bacteremia, CMV Viremia,
   SLE presents with fever and hypotension
   #SEPSIS- Patient presents with fevers, hyotension, tachycardia and a
   lactate of 4.8. In addition, her WBC is 4.0 but with an 8% bandemia.
   She has had a number of infections recently in the setting of
   immunosuppression. The differential is broad including line infection
   (new HD line placed on [**12-31**]), pneumonia (CXR without obvious
   infiltrate), CMV Viremia (viral load [**12-29**] negative), UTI, C. Diff
   (recent infection [**11-5**] but without any symptoms to suggest this).  Pt
   remained hemodynamically stable, however development of neutropenia.
   --Continue broad coverage with Meropenem (GN coverage) plus Daptomycin
   (GP coverage), will start PO Vanc given bandemia. Will consider
   addition of Cipro vs Gentamycin for double GN coverage pending
   hemodynamic stability
   --IVF for goal MAP>65
   --f/u CMV Viral load
   --Follow up blood cultures, send urine, line and stool cultures
   --Consider removal of line pending culture data
   -- consider ID consult in AM (prelim antibiotic choice per their recs)
   --Continue Midodrine per pts home regimen (for known hypotension)
   .
   #. Pancytopenia: Differential includes medications including linezolid
   and valcyte.  Additionally, could be secondary to infection although
   patient has remained hemodynamically stable.
   -- cont to trend CBC
   -- neutrapenic precautions
   -- holding linezolid and valcyte
   .
   # ESRD on HD s/p failed transplant:
   --WIll make renal aware
   --Continue nephrocaps
   --Continue HD per home schedule
   --Continue Prednisone and Dapsone
   .
   .
   # Venous thrombus: Patient was noted to have complete thrombosis
   of the left AV graft, left cephalic vein and left subclavian
   vein, and partial thrombosis of left brachiocephalic vein with
   extension to SVC on her previous admission.
   --Continue coumadin for goal INR [**12-31**]
   .
   # CMV viremia: Patinet has been treated with valganciclovir and
   followed by ID
   --Repeat CMV viral load
   --Continue valganciclovir (Tue/[**Last Name (un) 1554**])
   #Anemia- Hct 25 on admission (baseline 27-30); no active source of
   bleeding, known anemia/pancytopenia in setting of renal failure and
   possibley due to lupus
   --Guiac stools
   --Trend Hct
   --Continue EPO with HD
   #Hyperglycemia-Pt has known elevated FS in setting of steroids
   -Continue Insulin Sliding Scale
   .
   # PPX: PPI, Coumadin
   # ACCESS: Left EJ, PIV
   # CODE:FULL
   # CONTACT: [**Name (NI) 430**] [**Name (NI) 8128**], sister [**Telephone/Fax (1) 10948**]
   # DISPO: ICU
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   18 Gauge - [**2150-1-10**] 09:37 PM
   20 Gauge - [**2150-1-10**] 09:37 PM
   Dialysis Catheter - [**2150-1-10**] 10:32 PM
   Prophylaxis:
   DVT: (Systemic anticoagulation: Coumadin)
   Stress ulcer:
   VAP:
   Comments:
   Communication: Patient discussed on interdisciplinary rounds , Family
   meeting held , ICU consent signed Comments:
   Code status: Full code
   Disposition:Transfer to floor
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint:
   24 Hour Events:
   repeat EKG w/less TWF in V3-4, but persists in [**4-2**]
   -Cardiac enzymes CK 13, Trop 0.02
   -Repeat hct 20 (after IVF) but ordered1U prbcs (all cell lines down)
   but partially diluated; 23 this AM prior to transfusion
   - spoke with ID, cont new regimen (dapto/[**Last Name (un) **]/po vanco) until blood
   cultures/ c. diff return, then consider switching back or getting ID
   consult.
   - holding valgancyclovir given pancytopenia. Will await CMV VL and
   consider restarting.
   - CBC pancytopenia improving. Still with 6% bands
   - Renal Recs: Dialysis tuesday, hold valcyte pending CMV VL.
   - hemolysis labs negative
   - AM labs pancytopenia, pt placed on neutropenic precautions.
   Allergies:
   Bactrim Ds (Oral) (Sulfamethoxazole/Trimethoprim)
   Exfoliative [**Doctor Last Name **]
   Cellcept (Oral) (Mycophenolate Mofetil)
   Rash;
   Zosyn (Intraven) (Piperacillin Sodium/Tazobactam)
   Myelosuppressio
   Last dose of Antibiotics:
   Daptomycin - [**2150-1-11**] 04:19 AM
   Meropenem - [**2150-1-12**] 12:18 AM
   Vancomycin - [**2150-1-12**] 12:18 AM
   Infusions:
   Other ICU medications:
   Omeprazole (Prilosec) - [**2150-1-11**] 08:46 AM
   Coumadin (Warfarin) - [**2150-1-11**] 04:00 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2150-1-12**] 06:20 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**51**] AM
   Tmax: 36.9
C (98.5
   Tcurrent: 36.7
C (98
   HR: 79 (73 - 95) bpm
   BP: 109/72(81) {88/45(56) - 123/82(90)} mmHg
   RR: 20 (18 - 27) insp/min
   SpO2: 99%
   Heart rhythm: SR (Sinus Rhythm)
             Total In:
                                                                  2,765 mL
                                                                    163 mL
   PO:
                                                                  1,100 mL
             TF:
   IVF:
                                                                  1,290 mL
                                                                    163 mL
   Blood products:
                                                                    375 mL
   Total out:
                                                                    100 mL
                                                                      0 mL
   Urine:
                                                                    100 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  2,665 mL
                                                                    163 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 99%
   ABG: ///22/
   Physical Examination
   GENERAL: Ill appearing female
   HEENT: PERRL, O/P Clear, mucous membranes dry
   NECK: No lymphadenopathy, Left tunneled HD line in place, minimal
   erythema, no tenderness
   CARDIAC:  RRR no murmurs
   LUNG:  Clear bilaterally, no wheezing or rhonchi
   ABDOMEN:  Soft, NT, ND, +BS, palpated kidney on right lower quadrant
   EXT:  No clubbing, edema, warm and well pefused, 2+ DP/PT pulses
   bilatearlly
   NEURO:  Alert and oriented x3
   Labs / Radiology
   76 K/uL
   7.8 g/dL
   77 mg/dL
   4.2 mg/dL
   22 mEq/L
   3.6 mEq/L
   15 mg/dL
   107 mEq/L
   140 mEq/L
   25.3 %
   2.3 K/uL
        [image002.jpg]
                             [**2150-1-10**]  11:24 PM
                             [**2150-1-11**]  05:41 AM
                             [**2150-1-11**]  03:29 PM
                             [**2150-1-12**]  05:03 AM
   WBC
   2.9
   2.8
   3.5
   2.3
   Hct
   20.6
   23.1
   27.4
   25.3
   Plt
   65
   60
   96
   76
   Cr
   3.0
   3.1
   4.2
   TropT
   0.02
   0.02
   Glucose
   119
   74
   77
   Other labs: PT / PTT / INR:30.4/30.4/3.0, CK / CKMB /
   Troponin-T:17//0.02, Alk Phos / T Bili:/0.4, Differential-Neuts:26.0 %,
   Band:4.0 %, Lymph:62.0 %, Mono:5.0 %, Eos:2.0 %, Lactic Acid:1.4
   mmol/L, LDH:443 IU/L, Ca++:8.6 mg/dL, Mg++:2.0 mg/dL, PO4:2.8 mg/dL
   Assessment and Plan
 ANEMIA, CHRONIC
 DEEP VENOUS THROMBOSIS (DVT), UPPER EXTREMITY
 SEPSIS WITHOUT ORGAN DYSFUNCTION
 RENAL FAILURE, END STAGE (END STAGE RENAL DISEASE, ESRD)
 SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)
   52 year old female with ESRD on HD, recent VRE bacteremia, CMV Viremia,
   SLE presents with fever and hypotension
   #SEPSIS- Patient presents with fevers, hyotension, tachycardia and a
   lactate of 4.8. In addition, her WBC is 4.0 but with an 8% bandemia.
   She has had a number of infections recently in the setting of
   immunosuppression. The differential is broad including line infection
   (new HD line placed on [**12-31**]), pneumonia (CXR without obvious
   infiltrate), CMV Viremia (viral load [**12-29**] negative), UTI, C. Diff
   (recent infection [**11-5**] but without any symptoms to suggest this).  Pt
   remained hemodynamically stable, however development of neutropenia.
   --Continue broad coverage with Meropenem (GN coverage) plus Daptomycin
   (GP coverage), will start PO Vanc given bandemia. Will consider
   addition of Cipro vs Gentamycin for double GN coverage pending
   hemodynamic stability
   --IVF for goal MAP>65
   --f/u CMV Viral load
   --Follow up blood cultures, send urine, line and stool cultures
   --Consider removal of line pending culture data
   -- consider ID consult in AM (prelim antibiotic choice per their recs)
   --Continue Midodrine per pts home regimen (for known hypotension)
   .
   #. Pancytopenia: Differential includes medications including linezolid
   and valcyte.  Additionally, could be secondary to infection although
   patient has remained hemodynamically stable.
   -- cont to trend CBC
   -- neutrapenic precautions
   -- holding linezolid and valcyte
   .
   # ESRD on HD s/p failed transplant:
   --WIll make renal aware
   --Continue nephrocaps
   --Continue HD per home schedule
   --Continue Prednisone and Dapsone
   .
   .
   # Venous thrombus: Patient was noted to have complete thrombosis
   of the left AV graft, left cephalic vein and left subclavian
   vein, and partial thrombosis of left brachiocephalic vein with
   extension to SVC on her previous admission.
   --Continue coumadin for goal INR [**12-31**]
   .
   # CMV viremia: Patinet has been treated with valganciclovir and
   followed by ID
   --Repeat CMV viral load
   --Continue valganciclovir (Tue/[**Last Name (un) 1554**])
   #Anemia- Hct 25 on admission (baseline 27-30); no active source of
   bleeding, known anemia/pancytopenia in setting of renal failure and
   possibley due to lupus
   --Guiac stools
   --Trend Hct
   --Continue EPO with HD
   #Hyperglycemia-Pt has known elevated FS in setting of steroids
   -Continue Insulin Sliding Scale
   .
   # PPX: PPI, Coumadin
   # ACCESS: Left EJ, PIV
   # CODE:FULL
   # CONTACT: [**Name (NI) 430**] [**Name (NI) 8128**], sister [**Telephone/Fax (1) 10948**]
   # DISPO: ICU
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   18 Gauge - [**2150-1-10**] 09:37 PM
   20 Gauge - [**2150-1-10**] 09:37 PM
   Dialysis Catheter - [**2150-1-10**] 10:32 PM
   Prophylaxis:
   DVT: (Systemic anticoagulation: Coumadin)
   Stress ulcer:
   VAP:
   Comments:
   Communication: Patient discussed on interdisciplinary rounds , Family
   meeting held , ICU consent signed Comments:
   Code status: Full code
   Disposition:Transfer to floor<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the physician's daily progress note, the patient is a 52-year-old female with ESRD on HD, recent VRE bacteremia, CMV viremia, and SLE. She presents with fever, hypotension, tachycardia, and a lactate of 4.8. The patient has had a number of infections recently in the setting of immunosuppression.

The potential medical complications that can arise from the patient's condition include:

1. Sepsis: The patient's fever, hypotension, and tachycardia are indicative of sepsis. If left untreated, sepsis can progress to septic shock, organ failure, and death.
2. Renal failure: The patient has end-stage renal disease (ESRD) and is on HD. Any further decline in renal function can lead to acute kidney injury, uremia, and death.
3. Pancytopenia: The patient's pancytopenia is likely due to medication side effects, infection, or bone marrow suppression. Prolonged pancytopenia can increase the risk of bleeding, infection, and death.
4. CMV viremia: The patient's CMV viremia can lead to CMV disease, which can cause fever, rash, and multiorgan failure.
5. SLE: The patient's SLE can cause kidney damage, hypertension, and vasculitis, which can lead to organ failure and death.
6. DVT: The patient's DVT can lead to pulmonary embolism, which can be life-threatening.
7. Hyperglycemia: The patient's hyperglycemia can lead to ketoacidosis, hyperosmolar nonketotic syndrome, and death.
8. Anemia: The patient's anemia can lead to fatigue, shortness of breath, and decreased exercise tolerance.

The patient's current medications include:

* Daptomycin for VRE bacteremia
* Meropenem for broad-spectrum coverage
* Vancomycin for C. diff infection
* Valganciclovir for CMV viremia
* Coumadin for DVT prophylaxis
* Prednisone and Dapsone for SLE
* Midodrine for hypotension

The patient's lab results show:

* WBC: 4.0 with 8% bandemia
* Hct: 25.3
* Plt: 76
* Cr: 3.0
* TropT: 0.02
* Glucose: 119
* Lactic acid: 1.4 mmol/L
* LDH: 443 IU/L
* Ca++: 8.6 mg/dL
* Mg++: 2.0 mg/dL
* PO4: 2.8 mg/dL

The patient's vital signs are:

* Tmax: 36.9 C (98.5 F)
* Tcurrent: 36.7 C (98 F)
* HR: 79 bpm
* BP: 109/72 mmHg
* RR: 20 inspirations per minute
* SpO2: 99%

The patient's physical examination shows:

* General: Ill appearing female
* HEENT: PERRL, O/P clear, mucous membranes dry
* Neck: No lymphadenopathy, left tunneled HD line in place, minimal erythema, no tenderness
* Cardiac: RRR, no murmurs
* Lung: Clear bilaterally, no wheezing or rhonchi
* Abdomen: Soft, NT, ND, +BS, palpated kidney on right lower quadrant
* Ext: No clubbing, edema, warm and well perfused, 2+ DP/PT pulses bilaterally
* Neuro: Alert and oriented x3"
151778.0,205979,2150-01-12 06:33:00,Physician ,Physician Resident Progress Note,"Chief Complaint:
   24 Hour Events:
   repeat EKG w/less TWF in V3-4, but persists in [**4-2**]
   -Cardiac enzymes CK 13, Trop 0.02
   -Repeat hct 20 (after IVF) but ordered1U prbcs (all cell lines down)
   but partially diluated; 23 this AM prior to transfusion
   - spoke with ID, cont new regimen (dapto/[**Last Name (un) **]/po vanco) until blood
   cultures/ c. diff return, then consider switching back or getting ID
   consult.
   - holding valgancyclovir given pancytopenia. Will await CMV VL and
   consider restarting.
   - CBC pancytopenia improving. Still with 6% bands
   - Renal Recs: Dialysis tuesday, hold valcyte pending CMV VL.
   - hemolysis labs negative
   - AM labs pancytopenia, pt placed on neutropenic precautions.
   Allergies:
   Bactrim Ds (Oral) (Sulfamethoxazole/Trimethoprim)
   Exfoliative [**Doctor Last Name **]
   Cellcept (Oral) (Mycophenolate Mofetil)
   Rash;
   Zosyn (Intraven) (Piperacillin Sodium/Tazobactam)
   Myelosuppressio
   Last dose of Antibiotics:
   Daptomycin - [**2150-1-11**] 04:19 AM
   Meropenem - [**2150-1-12**] 12:18 AM
   Vancomycin - [**2150-1-12**] 12:18 AM
   Infusions:
   Other ICU medications:
   Omeprazole (Prilosec) - [**2150-1-11**] 08:46 AM
   Coumadin (Warfarin) - [**2150-1-11**] 04:00 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2150-1-12**] 06:20 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**51**] AM
   Tmax: 36.9
C (98.5
   Tcurrent: 36.7
C (98
   HR: 79 (73 - 95) bpm
   BP: 109/72(81) {88/45(56) - 123/82(90)} mmHg
   RR: 20 (18 - 27) insp/min
   SpO2: 99%
   Heart rhythm: SR (Sinus Rhythm)
             Total In:
                                                                  2,765 mL
                                                                    163 mL
   PO:
                                                                  1,100 mL
             TF:
   IVF:
                                                                  1,290 mL
                                                                    163 mL
   Blood products:
                                                                    375 mL
   Total out:
                                                                    100 mL
                                                                      0 mL
   Urine:
                                                                    100 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  2,665 mL
                                                                    163 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 99%
   ABG: ///22/
   Physical Examination
   GENERAL: Ill appearing female
   HEENT: PERRL, O/P Clear, mucous membranes dry
   NECK: No lymphadenopathy, Left tunneled HD line in place, minimal
   erythema, no tenderness
   CARDIAC:  RRR no murmurs
   LUNG:  Clear bilaterally, no wheezing or rhonchi
   ABDOMEN:  Soft, NT, ND, +BS, palpated kidney on right lower quadrant
   EXT:  No clubbing, edema, warm and well pefused, 2+ DP/PT pulses
   bilatearlly
   NEURO:  Alert and oriented x3
   Labs / Radiology
   76 K/uL
   7.8 g/dL
   77 mg/dL
   4.2 mg/dL
   22 mEq/L
   3.6 mEq/L
   15 mg/dL
   107 mEq/L
   140 mEq/L
   25.3 %
   2.3 K/uL
        [image002.jpg]
                             [**2150-1-10**]  11:24 PM
                             [**2150-1-11**]  05:41 AM
                             [**2150-1-11**]  03:29 PM
                             [**2150-1-12**]  05:03 AM
   WBC
   2.9
   2.8
   3.5
   2.3
   Hct
   20.6
   23.1
   27.4
   25.3
   Plt
   65
   60
   96
   76
   Cr
   3.0
   3.1
   4.2
   TropT
   0.02
   0.02
   Glucose
   119
   74
   77
   Other labs: PT / PTT / INR:30.4/30.4/3.0, CK / CKMB /
   Troponin-T:17//0.02, Alk Phos / T Bili:/0.4, Differential-Neuts:26.0 %,
   Band:4.0 %, Lymph:62.0 %, Mono:5.0 %, Eos:2.0 %, Lactic Acid:1.4
   mmol/L, LDH:443 IU/L, Ca++:8.6 mg/dL, Mg++:2.0 mg/dL, PO4:2.8 mg/dL
   Assessment and Plan
 ANEMIA, CHRONIC
 DEEP VENOUS THROMBOSIS (DVT), UPPER EXTREMITY
 SEPSIS WITHOUT ORGAN DYSFUNCTION
 RENAL FAILURE, END STAGE (END STAGE RENAL DISEASE, ESRD)
 SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)
   52 year old female with ESRD on HD, recent VRE bacteremia, CMV Viremia,
   SLE presents with fever and hypotension
   #SEPSIS- Patient presents with fevers, hyotension, tachycardia and a
   lactate of 4.8. In addition, her WBC is 4.0 but with an 8% bandemia.
   She has had a number of infections recently in the setting of
   immunosuppression. The differential is broad including line infection
   (new HD line placed on [**12-31**]), pneumonia (CXR without obvious
   infiltrate), CMV Viremia (viral load [**12-29**] negative), UTI, C. Diff
   (recent infection [**11-5**] but without any symptoms to suggest this).  Pt
   remained hemodynamically stable, however development of neutropenia.
   --Continue broad coverage with Meropenem (GN coverage) plus Daptomycin
   (GP coverage), will start PO Vanc given bandemia. Will consider
   addition of Cipro vs Gentamycin for double GN coverage pending
   hemodynamic stability
   --IVF for goal MAP>65
   --f/u CMV Viral load
   --Follow up blood cultures, send urine, line and stool cultures
   --Consider removal of line pending culture data
   -- consider ID consult in AM (prelim antibiotic choice per their recs)
   --Continue Midodrine per pts home regimen (for known hypotension)
   .
   #. Pancytopenia: Differential includes medications including linezolid
   and valcyte.  Additionally, could be secondary to infection although
   patient has remained hemodynamically stable.
   -- cont to trend CBC
   -- neutrapenic precautions
   -- holding linezolid and valcyte
   .
   # ESRD on HD s/p failed transplant:
   --WIll make renal aware
   --Continue nephrocaps
   --Continue HD per home schedule
   --Continue Prednisone and Dapsone
   .
   .
   # Venous thrombus: Patient was noted to have complete thrombosis
   of the left AV graft, left cephalic vein and left subclavian
   vein, and partial thrombosis of left brachiocephalic vein with
   extension to SVC on her previous admission.
   --Continue coumadin for goal INR [**12-31**]
   .
   # CMV viremia: Patinet has been treated with valganciclovir and
   followed by ID
   --Repeat CMV viral load
   --Continue valganciclovir (Tue/[**Last Name (un) 1554**])
   #Anemia- Hct 25 on admission (baseline 27-30); no active source of
   bleeding, known anemia/pancytopenia in setting of renal failure and
   possibley due to lupus
   --Guiac stools
   --Trend Hct
   --Continue EPO with HD
   #Hyperglycemia-Pt has known elevated FS in setting of steroids
   -Continue Insulin Sliding Scale
   .
   # PPX: PPI, Coumadin
   # ACCESS: Left EJ, PIV
   # CODE:FULL
   # CONTACT: [**Name (NI) 430**] [**Name (NI) 8128**], sister [**Telephone/Fax (1) 10948**]
   # DISPO: ICU
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   18 Gauge - [**2150-1-10**] 09:37 PM
   20 Gauge - [**2150-1-10**] 09:37 PM
   Dialysis Catheter - [**2150-1-10**] 10:32 PM
   Prophylaxis:
   DVT: (Systemic anticoagulation: Coumadin)
   Stress ulcer:
   VAP:
   Comments:
   Communication: Patient discussed on interdisciplinary rounds , Family
   meeting held , ICU consent signed Comments:
   Code status: Full code
   Disposition:Transfer to floor
   ------ Protected Section ------
   Pt seen and evaluated. Please see details of history and plan as
   outlined above.
   In addition:
   Cardiac enzymes flat.  Hct 20 = transfused 1 unit
   Dapto/Meropenem/ po Vanco
   ANC 600 this AM
   C Diff was negative
   PE:
   Alert, comfortable
   Lungs Clear
   HS normal
   Abdomen
 BS active/non-tender/soft
   Extrem
 no edema
   Plan:
   BP has been stable
   Source of infection unclear
   Continuing AB per ID recs
   Okay for transfer to floor
   Time Spent: 30
   ------ Protected Section Addendum Entered By:[**Name (NI) **] [**Last Name (NamePattern1) **], MD
   on:[**2150-1-12**] 11:29 ------
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint:
   24 Hour Events:
   repeat EKG w/less TWF in V3-4, but persists in [**4-2**]
   -Cardiac enzymes CK 13, Trop 0.02
   -Repeat hct 20 (after IVF) but ordered1U prbcs (all cell lines down)
   but partially diluated; 23 this AM prior to transfusion
   - spoke with ID, cont new regimen (dapto/[**Last Name (un) **]/po vanco) until blood
   cultures/ c. diff return, then consider switching back or getting ID
   consult.
   - holding valgancyclovir given pancytopenia. Will await CMV VL and
   consider restarting.
   - CBC pancytopenia improving. Still with 6% bands
   - Renal Recs: Dialysis tuesday, hold valcyte pending CMV VL.
   - hemolysis labs negative
   - AM labs pancytopenia, pt placed on neutropenic precautions.
   Allergies:
   Bactrim Ds (Oral) (Sulfamethoxazole/Trimethoprim)
   Exfoliative [**Doctor Last Name **]
   Cellcept (Oral) (Mycophenolate Mofetil)
   Rash;
   Zosyn (Intraven) (Piperacillin Sodium/Tazobactam)
   Myelosuppressio
   Last dose of Antibiotics:
   Daptomycin - [**2150-1-11**] 04:19 AM
   Meropenem - [**2150-1-12**] 12:18 AM
   Vancomycin - [**2150-1-12**] 12:18 AM
   Infusions:
   Other ICU medications:
   Omeprazole (Prilosec) - [**2150-1-11**] 08:46 AM
   Coumadin (Warfarin) - [**2150-1-11**] 04:00 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2150-1-12**] 06:20 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**51**] AM
   Tmax: 36.9
C (98.5
   Tcurrent: 36.7
C (98
   HR: 79 (73 - 95) bpm
   BP: 109/72(81) {88/45(56) - 123/82(90)} mmHg
   RR: 20 (18 - 27) insp/min
   SpO2: 99%
   Heart rhythm: SR (Sinus Rhythm)
             Total In:
                                                                  2,765 mL
                                                                    163 mL
   PO:
                                                                  1,100 mL
             TF:
   IVF:
                                                                  1,290 mL
                                                                    163 mL
   Blood products:
                                                                    375 mL
   Total out:
                                                                    100 mL
                                                                      0 mL
   Urine:
                                                                    100 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  2,665 mL
                                                                    163 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 99%
   ABG: ///22/
   Physical Examination
   GENERAL: Ill appearing female
   HEENT: PERRL, O/P Clear, mucous membranes dry
   NECK: No lymphadenopathy, Left tunneled HD line in place, minimal
   erythema, no tenderness
   CARDIAC:  RRR no murmurs
   LUNG:  Clear bilaterally, no wheezing or rhonchi
   ABDOMEN:  Soft, NT, ND, +BS, palpated kidney on right lower quadrant
   EXT:  No clubbing, edema, warm and well pefused, 2+ DP/PT pulses
   bilatearlly
   NEURO:  Alert and oriented x3
   Labs / Radiology
   76 K/uL
   7.8 g/dL
   77 mg/dL
   4.2 mg/dL
   22 mEq/L
   3.6 mEq/L
   15 mg/dL
   107 mEq/L
   140 mEq/L
   25.3 %
   2.3 K/uL
        [image002.jpg]
                             [**2150-1-10**]  11:24 PM
                             [**2150-1-11**]  05:41 AM
                             [**2150-1-11**]  03:29 PM
                             [**2150-1-12**]  05:03 AM
   WBC
   2.9
   2.8
   3.5
   2.3
   Hct
   20.6
   23.1
   27.4
   25.3
   Plt
   65
   60
   96
   76
   Cr
   3.0
   3.1
   4.2
   TropT
   0.02
   0.02
   Glucose
   119
   74
   77
   Other labs: PT / PTT / INR:30.4/30.4/3.0, CK / CKMB /
   Troponin-T:17//0.02, Alk Phos / T Bili:/0.4, Differential-Neuts:26.0 %,
   Band:4.0 %, Lymph:62.0 %, Mono:5.0 %, Eos:2.0 %, Lactic Acid:1.4
   mmol/L, LDH:443 IU/L, Ca++:8.6 mg/dL, Mg++:2.0 mg/dL, PO4:2.8 mg/dL
   Assessment and Plan
 ANEMIA, CHRONIC
 DEEP VENOUS THROMBOSIS (DVT), UPPER EXTREMITY
 SEPSIS WITHOUT ORGAN DYSFUNCTION
 RENAL FAILURE, END STAGE (END STAGE RENAL DISEASE, ESRD)
 SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)
   52 year old female with ESRD on HD, recent VRE bacteremia, CMV Viremia,
   SLE presents with fever and hypotension
   #SEPSIS- Patient presents with fevers, hyotension, tachycardia and a
   lactate of 4.8. In addition, her WBC is 4.0 but with an 8% bandemia.
   She has had a number of infections recently in the setting of
   immunosuppression. The differential is broad including line infection
   (new HD line placed on [**12-31**]), pneumonia (CXR without obvious
   infiltrate), CMV Viremia (viral load [**12-29**] negative), UTI, C. Diff
   (recent infection [**11-5**] but without any symptoms to suggest this).  Pt
   remained hemodynamically stable, however development of neutropenia.
   --Continue broad coverage with Meropenem (GN coverage) plus Daptomycin
   (GP coverage), will start PO Vanc given bandemia. Will consider
   addition of Cipro vs Gentamycin for double GN coverage pending
   hemodynamic stability
   --IVF for goal MAP>65
   --f/u CMV Viral load
   --Follow up blood cultures, send urine, line and stool cultures
   --Consider removal of line pending culture data
   -- consider ID consult in AM (prelim antibiotic choice per their recs)
   --Continue Midodrine per pts home regimen (for known hypotension)
   .
   #. Pancytopenia: Differential includes medications including linezolid
   and valcyte.  Additionally, could be secondary to infection although
   patient has remained hemodynamically stable.
   -- cont to trend CBC
   -- neutrapenic precautions
   -- holding linezolid and valcyte
   .
   # ESRD on HD s/p failed transplant:
   --WIll make renal aware
   --Continue nephrocaps
   --Continue HD per home schedule
   --Continue Prednisone and Dapsone
   .
   .
   # Venous thrombus: Patient was noted to have complete thrombosis
   of the left AV graft, left cephalic vein and left subclavian
   vein, and partial thrombosis of left brachiocephalic vein with
   extension to SVC on her previous admission.
   --Continue coumadin for goal INR [**12-31**]
   .
   # CMV viremia: Patinet has been treated with valganciclovir and
   followed by ID
   --Repeat CMV viral load
   --Continue valganciclovir (Tue/[**Last Name (un) 1554**])
   #Anemia- Hct 25 on admission (baseline 27-30); no active source of
   bleeding, known anemia/pancytopenia in setting of renal failure and
   possibley due to lupus
   --Guiac stools
   --Trend Hct
   --Continue EPO with HD
   #Hyperglycemia-Pt has known elevated FS in setting of steroids
   -Continue Insulin Sliding Scale
   .
   # PPX: PPI, Coumadin
   # ACCESS: Left EJ, PIV
   # CODE:FULL
   # CONTACT: [**Name (NI) 430**] [**Name (NI) 8128**], sister [**Telephone/Fax (1) 10948**]
   # DISPO: ICU
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   18 Gauge - [**2150-1-10**] 09:37 PM
   20 Gauge - [**2150-1-10**] 09:37 PM
   Dialysis Catheter - [**2150-1-10**] 10:32 PM
   Prophylaxis:
   DVT: (Systemic anticoagulation: Coumadin)
   Stress ulcer:
   VAP:
   Comments:
   Communication: Patient discussed on interdisciplinary rounds , Family
   meeting held , ICU consent signed Comments:
   Code status: Full code
   Disposition:Transfer to floor
   ------ Protected Section ------
   Pt seen and evaluated. Please see details of history and plan as
   outlined above.
   In addition:
   Cardiac enzymes flat.  Hct 20 = transfused 1 unit
   Dapto/Meropenem/ po Vanco
   ANC 600 this AM
   C Diff was negative
   PE:
   Alert, comfortable
   Lungs Clear
   HS normal
   Abdomen
 BS active/non-tender/soft
   Extrem
 no edema
   Plan:
   BP has been stable
   Source of infection unclear
   Continuing AB per ID recs
   Okay for transfer to floor
   Time Spent: 30
   ------ Protected Section Addendum Entered By:[**Name (NI) **] [**Last Name (NamePattern1) **], MD
   on:[**2150-1-12**] 11:29 ------<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Summary:

The patient is a 52-year-old female with End Stage Renal Disease (ESRD) on hemodialysis, recent VRE bacteremia, and CMV viremia. She presents with fever, hypotension, tachycardia, and a lactate of 4.8. The differential diagnosis includes line infection, pneumonia, CMV viremia, UTI, and C. diff. The patient has developed neutropenia, and her CBC is trending towards improvement.

Potential Medical Complications:

1. Sepsis: The patient's sepsis is not responding to antibiotics, and the source of infection is unclear. This may lead to further complications, such as organ dysfunction and mortality.
2. Pancytopenia: The patient's pancytopenia is likely secondary to medications, including linezolid and valcyte, as well as infection. Further monitoring of the CBC is necessary to ensure that the patient's pancytopenia does not worsen.
3. Renal Failure: The patient has End Stage Renal Disease (ESRD) and is on hemodialysis. Further complications, such as acute kidney injury or worsening of ESRD, may occur if the patient's renal function does not improve.
4. CMV Viremia: The patient has been treated with valganciclovir, but further monitoring of the CMV viral load is necessary to ensure that the patient's viremia is under control.
5. Anemia: The patient has chronic anemia, and further monitoring of her hemoglobin and hematocrit is necessary to ensure that her anemia does not worsen.
6. Hyperglycemia: The patient has known elevated fasting serum glucose levels, and further monitoring of her blood glucose levels is necessary to ensure that her hyperglycemia is under control.
7. Venous Thrombosis: The patient has a history of deep venous thrombosis (DVT) and is currently receiving coumadin therapy. Further monitoring of her thrombotic risk factors is necessary to ensure that she does not develop further thrombotic complications.
8. Lupus: The patient has Systemic Lupus Erythematosus (SLE), which may increase her risk of developing further complications, such as nephritis or vasculitis. Further monitoring of her lupus activity is necessary to ensure that her disease is under control.

Overall, the patient requires close monitoring and management to prevent and treat these potential complications."
151778.0,205979,2150-01-12 06:33:00,Physician ,Physician Resident Progress Note,"Chief Complaint:
   24 Hour Events:
   repeat EKG w/less TWF in V3-4, but persists in [**4-2**]
   -Cardiac enzymes CK 13, Trop 0.02
   -Repeat hct 20 (after IVF) but ordered1U prbcs (all cell lines down)
   but partially diluated; 23 this AM prior to transfusion
   - spoke with ID, cont new regimen (dapto/[**Last Name (un) **]/po vanco) until blood
   cultures/ c. diff return, then consider switching back or getting ID
   consult.
   - holding valgancyclovir given pancytopenia. Will await CMV VL and
   consider restarting.
   - CBC pancytopenia improving. Still with 6% bands
   - Renal Recs: Dialysis tuesday, hold valcyte pending CMV VL.
   - hemolysis labs negative
   - AM labs pancytopenia, pt placed on neutrapenic precautions.
   Allergies:
   Bactrim Ds (Oral) (Sulfamethoxazole/Trimethoprim)
   Exfoliative [**Doctor Last Name **]
   Cellcept (Oral) (Mycophenolate Mofetil)
   Rash;
   Zosyn (Intraven) (Piperacillin Sodium/Tazobactam)
   Myelosuppressio
   Last dose of Antibiotics:
   Daptomycin - [**2150-1-11**] 04:19 AM
   Meropenem - [**2150-1-12**] 12:18 AM
   Vancomycin - [**2150-1-12**] 12:18 AM
   Infusions:
   Other ICU medications:
   Omeprazole (Prilosec) - [**2150-1-11**] 08:46 AM
   Coumadin (Warfarin) - [**2150-1-11**] 04:00 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2150-1-12**] 06:20 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**51**] AM
   Tmax: 36.9
C (98.5
   Tcurrent: 36.7
C (98
   HR: 79 (73 - 95) bpm
   BP: 109/72(81) {88/45(56) - 123/82(90)} mmHg
   RR: 20 (18 - 27) insp/min
   SpO2: 99%
   Heart rhythm: SR (Sinus Rhythm)
             Total In:
                                                                  2,765 mL
                                                                    163 mL
   PO:
                                                                  1,100 mL
             TF:
   IVF:
                                                                  1,290 mL
                                                                    163 mL
   Blood products:
                                                                    375 mL
   Total out:
                                                                    100 mL
                                                                      0 mL
   Urine:
                                                                    100 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  2,665 mL
                                                                    163 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 99%
   ABG: ///22/
   Physical Examination
   GENERAL: Ill appearing female
   HEENT: PERRL, O/P Clear, mucous membranes dry
   NECK: No lymphadenopathy, Left tunneled HD line in place, minimal
   erythema, no tenderness
   CARDIAC:  RRR no murmurs
   LUNG:  Clear bilaterally, no wheezing or rhonchi
   ABDOMEN:  Soft, NT, ND, +BS, palpated kidney on right lower quadrant
   EXT:  No clubbing, edema, warm and well pefused, 2+ DP/PT pulses
   bilatearlly
   NEURO:  Alert and oriented x3
   Labs / Radiology
   76 K/uL
   7.8 g/dL
   77 mg/dL
   4.2 mg/dL
   22 mEq/L
   3.6 mEq/L
   15 mg/dL
   107 mEq/L
   140 mEq/L
   25.3 %
   2.3 K/uL
        [image002.jpg]
                             [**2150-1-10**]  11:24 PM
                             [**2150-1-11**]  05:41 AM
                             [**2150-1-11**]  03:29 PM
                             [**2150-1-12**]  05:03 AM
   WBC
   2.9
   2.8
   3.5
   2.3
   Hct
   20.6
   23.1
   27.4
   25.3
   Plt
   65
   60
   96
   76
   Cr
   3.0
   3.1
   4.2
   TropT
   0.02
   0.02
   Glucose
   119
   74
   77
   Other labs: PT / PTT / INR:30.4/30.4/3.0, CK / CKMB /
   Troponin-T:17//0.02, Alk Phos / T Bili:/0.4, Differential-Neuts:26.0 %,
   Band:4.0 %, Lymph:62.0 %, Mono:5.0 %, Eos:2.0 %, Lactic Acid:1.4
   mmol/L, LDH:443 IU/L, Ca++:8.6 mg/dL, Mg++:2.0 mg/dL, PO4:2.8 mg/dL
   Assessment and Plan
 ANEMIA, CHRONIC
 DEEP VENOUS THROMBOSIS (DVT), UPPER EXTREMITY
 SEPSIS WITHOUT ORGAN DYSFUNCTION
 RENAL FAILURE, END STAGE (END STAGE RENAL DISEASE, ESRD)
 SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)
   52 year old female with ESRD on HD, recent VRE bacteremia, CMV Viremia,
   SLE presents with fever and hypotension
   #SEPSIS- Patient presents with fevers, hyotension, tachycardia and a
   lactate of 4.8. In addition, her WBC is 4.0 but with an 8% bandemia.
   She has had a number of infections recently in the setting of
   immunosuppression. The differential is broad including line infection
   (new HD line placed on [**12-31**]), pneumonia (CXR without obvious
   infiltrate), CMV Viremia (viral load [**12-29**] negative), UTI, C. Diff
   (recent infection [**11-5**] but without any symptoms to suggest this).  Pt
   remained hemodynamically stable, however development of neutropenia.
   --Continue broad coverage with Meropenem (GN coverage) plus Daptomycin
   (GP coverage), will start PO Vanc given bandemia. Will consider
   addition of Cipro vs Gentamycin for double GN coverage pending
   hemodynamic stability
   --IVF for goal MAP>65
   --f/u CMV Viral load
   --Follow up blood cultures, send urine, line and stool cultures
   --Consider removal of line pending culture data
   -- consider ID consult in AM (prelim antibiotic choice per their recs)
   --Continue Midodrine per pts home regimen (for known hypotension)
   .
   #. Pancytopenia: Differential includes medications including linezolid
   and valcyte.  Additionally, could be secondary to infection although
   patient has remained hemodynamically stable.
   -- cont to trend CBC
   -- neutrapenic precautions
   -- holding linezolid and valcyte
   .
   # ESRD on HD s/p failed transplant:
   --WIll make renal aware
   --Continue nephrocaps
   --Continue HD per home schedule
   --Continue Prednisone and Dapsone
   .
   .
   # Venous thrombus: Patient was noted to have complete thrombosis
   of the left AV graft, left cephalic vein and left subclavian
   vein, and partial thrombosis of left brachiocephalic vein with
   extension to SVC on her previous admission.
   --Continue coumadin for goal INR [**12-31**]
   .
   # CMV viremia: Patinet has been treated with valganciclovir and
   followed by ID
   --Repeat CMV viral load
   --Continue valganciclovir (Tue/[**Last Name (un) 1554**])
   #Anemia- Hct 25 on admission (baseline 27-30); no active source of
   bleeding, known anemia/pancytopenia in setting of renal failure and
   possibley due to lupus
   --Guiac stools
   --Trend Hct
   --Continue EPO with HD
   #Hyperglycemia-Pt has known elevated FS in setting of steroids
   -Continue Insulin Sliding Scale
   .
   # PPX: PPI, Coumadin
   # ACCESS: Left EJ, PIV
   # CODE:FULL
   # CONTACT: [**Name (NI) 430**] [**Name (NI) 8128**], sister [**Telephone/Fax (1) 10948**]
   # DISPO: ICU
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   18 Gauge - [**2150-1-10**] 09:37 PM
   20 Gauge - [**2150-1-10**] 09:37 PM
   Dialysis Catheter - [**2150-1-10**] 10:32 PM
   Prophylaxis:
   DVT: (Systemic anticoagulation: Coumadin)
   Stress ulcer:
   VAP:
   Comments:
   Communication: Patient discussed on interdisciplinary rounds , Family
   meeting held , ICU consent signed Comments:
   Code status: Full code
   Disposition:Transfer to floor
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint:
   24 Hour Events:
   repeat EKG w/less TWF in V3-4, but persists in [**4-2**]
   -Cardiac enzymes CK 13, Trop 0.02
   -Repeat hct 20 (after IVF) but ordered1U prbcs (all cell lines down)
   but partially diluated; 23 this AM prior to transfusion
   - spoke with ID, cont new regimen (dapto/[**Last Name (un) **]/po vanco) until blood
   cultures/ c. diff return, then consider switching back or getting ID
   consult.
   - holding valgancyclovir given pancytopenia. Will await CMV VL and
   consider restarting.
   - CBC pancytopenia improving. Still with 6% bands
   - Renal Recs: Dialysis tuesday, hold valcyte pending CMV VL.
   - hemolysis labs negative
   - AM labs pancytopenia, pt placed on neutrapenic precautions.
   Allergies:
   Bactrim Ds (Oral) (Sulfamethoxazole/Trimethoprim)
   Exfoliative [**Doctor Last Name **]
   Cellcept (Oral) (Mycophenolate Mofetil)
   Rash;
   Zosyn (Intraven) (Piperacillin Sodium/Tazobactam)
   Myelosuppressio
   Last dose of Antibiotics:
   Daptomycin - [**2150-1-11**] 04:19 AM
   Meropenem - [**2150-1-12**] 12:18 AM
   Vancomycin - [**2150-1-12**] 12:18 AM
   Infusions:
   Other ICU medications:
   Omeprazole (Prilosec) - [**2150-1-11**] 08:46 AM
   Coumadin (Warfarin) - [**2150-1-11**] 04:00 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2150-1-12**] 06:20 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**51**] AM
   Tmax: 36.9
C (98.5
   Tcurrent: 36.7
C (98
   HR: 79 (73 - 95) bpm
   BP: 109/72(81) {88/45(56) - 123/82(90)} mmHg
   RR: 20 (18 - 27) insp/min
   SpO2: 99%
   Heart rhythm: SR (Sinus Rhythm)
             Total In:
                                                                  2,765 mL
                                                                    163 mL
   PO:
                                                                  1,100 mL
             TF:
   IVF:
                                                                  1,290 mL
                                                                    163 mL
   Blood products:
                                                                    375 mL
   Total out:
                                                                    100 mL
                                                                      0 mL
   Urine:
                                                                    100 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  2,665 mL
                                                                    163 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 99%
   ABG: ///22/
   Physical Examination
   GENERAL: Ill appearing female
   HEENT: PERRL, O/P Clear, mucous membranes dry
   NECK: No lymphadenopathy, Left tunneled HD line in place, minimal
   erythema, no tenderness
   CARDIAC:  RRR no murmurs
   LUNG:  Clear bilaterally, no wheezing or rhonchi
   ABDOMEN:  Soft, NT, ND, +BS, palpated kidney on right lower quadrant
   EXT:  No clubbing, edema, warm and well pefused, 2+ DP/PT pulses
   bilatearlly
   NEURO:  Alert and oriented x3
   Labs / Radiology
   76 K/uL
   7.8 g/dL
   77 mg/dL
   4.2 mg/dL
   22 mEq/L
   3.6 mEq/L
   15 mg/dL
   107 mEq/L
   140 mEq/L
   25.3 %
   2.3 K/uL
        [image002.jpg]
                             [**2150-1-10**]  11:24 PM
                             [**2150-1-11**]  05:41 AM
                             [**2150-1-11**]  03:29 PM
                             [**2150-1-12**]  05:03 AM
   WBC
   2.9
   2.8
   3.5
   2.3
   Hct
   20.6
   23.1
   27.4
   25.3
   Plt
   65
   60
   96
   76
   Cr
   3.0
   3.1
   4.2
   TropT
   0.02
   0.02
   Glucose
   119
   74
   77
   Other labs: PT / PTT / INR:30.4/30.4/3.0, CK / CKMB /
   Troponin-T:17//0.02, Alk Phos / T Bili:/0.4, Differential-Neuts:26.0 %,
   Band:4.0 %, Lymph:62.0 %, Mono:5.0 %, Eos:2.0 %, Lactic Acid:1.4
   mmol/L, LDH:443 IU/L, Ca++:8.6 mg/dL, Mg++:2.0 mg/dL, PO4:2.8 mg/dL
   Assessment and Plan
 ANEMIA, CHRONIC
 DEEP VENOUS THROMBOSIS (DVT), UPPER EXTREMITY
 SEPSIS WITHOUT ORGAN DYSFUNCTION
 RENAL FAILURE, END STAGE (END STAGE RENAL DISEASE, ESRD)
 SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)
   52 year old female with ESRD on HD, recent VRE bacteremia, CMV Viremia,
   SLE presents with fever and hypotension
   #SEPSIS- Patient presents with fevers, hyotension, tachycardia and a
   lactate of 4.8. In addition, her WBC is 4.0 but with an 8% bandemia.
   She has had a number of infections recently in the setting of
   immunosuppression. The differential is broad including line infection
   (new HD line placed on [**12-31**]), pneumonia (CXR without obvious
   infiltrate), CMV Viremia (viral load [**12-29**] negative), UTI, C. Diff
   (recent infection [**11-5**] but without any symptoms to suggest this).  Pt
   remained hemodynamically stable, however development of neutropenia.
   --Continue broad coverage with Meropenem (GN coverage) plus Daptomycin
   (GP coverage), will start PO Vanc given bandemia. Will consider
   addition of Cipro vs Gentamycin for double GN coverage pending
   hemodynamic stability
   --IVF for goal MAP>65
   --f/u CMV Viral load
   --Follow up blood cultures, send urine, line and stool cultures
   --Consider removal of line pending culture data
   -- consider ID consult in AM (prelim antibiotic choice per their recs)
   --Continue Midodrine per pts home regimen (for known hypotension)
   .
   #. Pancytopenia: Differential includes medications including linezolid
   and valcyte.  Additionally, could be secondary to infection although
   patient has remained hemodynamically stable.
   -- cont to trend CBC
   -- neutrapenic precautions
   -- holding linezolid and valcyte
   .
   # ESRD on HD s/p failed transplant:
   --WIll make renal aware
   --Continue nephrocaps
   --Continue HD per home schedule
   --Continue Prednisone and Dapsone
   .
   .
   # Venous thrombus: Patient was noted to have complete thrombosis
   of the left AV graft, left cephalic vein and left subclavian
   vein, and partial thrombosis of left brachiocephalic vein with
   extension to SVC on her previous admission.
   --Continue coumadin for goal INR [**12-31**]
   .
   # CMV viremia: Patinet has been treated with valganciclovir and
   followed by ID
   --Repeat CMV viral load
   --Continue valganciclovir (Tue/[**Last Name (un) 1554**])
   #Anemia- Hct 25 on admission (baseline 27-30); no active source of
   bleeding, known anemia/pancytopenia in setting of renal failure and
   possibley due to lupus
   --Guiac stools
   --Trend Hct
   --Continue EPO with HD
   #Hyperglycemia-Pt has known elevated FS in setting of steroids
   -Continue Insulin Sliding Scale
   .
   # PPX: PPI, Coumadin
   # ACCESS: Left EJ, PIV
   # CODE:FULL
   # CONTACT: [**Name (NI) 430**] [**Name (NI) 8128**], sister [**Telephone/Fax (1) 10948**]
   # DISPO: ICU
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   18 Gauge - [**2150-1-10**] 09:37 PM
   20 Gauge - [**2150-1-10**] 09:37 PM
   Dialysis Catheter - [**2150-1-10**] 10:32 PM
   Prophylaxis:
   DVT: (Systemic anticoagulation: Coumadin)
   Stress ulcer:
   VAP:
   Comments:
   Communication: Patient discussed on interdisciplinary rounds , Family
   meeting held , ICU consent signed Comments:
   Code status: Full code
   Disposition:Transfer to floor<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Summary:

The patient is a 52-year-old female with End Stage Renal Disease (ESRD) on hemodialysis (HD), recent VRE bacteremia, CMV viremia, and Systemic Lupus Erythematosus (SLE). She presented with fever, hypotension, and tachycardia, meeting criteria for sepsis without organ dysfunction. She has a history of infections, including line infection, pneumonia, CMV viremia, UTI, and C. Diff infection. Her recent lab results show pancytopenia, with a WBC count of 4.0 and 8% bandemia. She has a history of anemia, and her current Hct is 25.

Potential Medical Complications:

1. Sepsis: The patient's sepsis is ongoing, and she may continue to develop septic shock if not adequately treated.
2. Pancytopenia: The patient's pancytopenia is a concern, and she may be at risk for bleeding or infection if not managed properly.
3. Anemia: The patient's anemia is ongoing, and she may require further management to prevent complications.
4. Hyperglycemia: The patient's hyperglycemia is ongoing, and she may require further management to prevent complications.
5. Renal failure: The patient's ESRD is ongoing, and she may require further management to prevent complications.
6. CMV viremia: The patient's CMV viremia is ongoing, and she may require further management to prevent complications.
7. VRE bacteremia: The patient's VRE bacteremia is ongoing, and she may require further management to prevent complications.
8. Deep Vein Thrombosis (DVT): The patient has a history of DVT, and she may be at risk for further thrombotic complications if not adequately managed.

Recommendations:

1. Continue broad-spectrum antibiotics to cover potential infections.
2. Monitor the patient's pancytopenia and adjust treatment as necessary.
3. Manage the patient's anemia and hyperglycemia with ongoing therapy.
4. Continue renal replacement therapy (RRT) as scheduled.
5. Monitor the patient's CMV viremia and adjust treatment as necessary.
6. Consider removing the central venous catheter (CVC) if cultures are positive.
7. Continue anticoagulation therapy to prevent further thrombotic complications.
8. Consider consulting Infectious Disease (ID) and Nephrology services for further management."
151778.0,205979,2150-01-14 07:49:00,Physician ,Physician Resident Progress Note,"Chief Complaint:
   24 Hour Events:
   HD in room overnight
   -Developed Afib with rapid rate to 120s-130s, controlled to 100s with
   Digoxin PO x1.  No hypotension
   - vancomycin and meropenem stopped given lack of clear indication
   - metoprolol changed to digoxin per recommendation of renal to better
   support BP
   Allergies:
   Bactrim Ds (Oral) (Sulfamethoxazole/Trimethoprim)
   Exfoliative [**Doctor Last Name **]
   Cellcept (Oral) (Mycophenolate Mofetil)
   Rash;
   Zosyn (Intraven) (Piperacillin Sodium/Tazobactam)
   Myelosuppressio
   Last dose of Antibiotics:
   Vancomycin - [**2150-1-12**] 06:29 AM
   Meropenem - [**2150-1-12**] 12:28 PM
   Infusions:
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2150-1-14**] 07:48 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**51**] AM
   Tmax: 36.9
C (98.4
   Tcurrent: 36.8
C (98.2
   HR: 100 (71 - 121) bpm
   BP: 95/61(67) {88/52(62) - 113/80(177)} mmHg
   RR: 15 (15 - 24) insp/min
   SpO2: 97%
   Heart rhythm: AF (Atrial Fibrillation)
             Total In:
                                                                    161 mL
                                                                     78 mL
   PO:
             TF:
   IVF:
                                                                    161 mL
                                                                     78 mL
   Blood products:
   Total out:
                                                                      0 mL
                                                                      0 mL
   Urine:
   NG:
   Stool:
   Drains:
   Balance:
                                                                    161 mL
                                                                     78 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 97%
   ABG: ///30/
   Physical Examination
   GEN: The patient is in no acute distress
   SKIN: Pale, No rashes or skin changes noted
   HEENT: Distended neck veins to mandible, neck supple, No
   lymphadenopathy in cervical, posterior, or supraclavicular chains
   noted.
   CHEST: Lungs with soft bibasilar crackles
   CARDIAC: reg rhythm, loud crisp sounding S2 over RUSB, [**1-31**] holosystolic
   murmur at left sternal border
   ABDOMEN: Non-distended, and soft without tenderness
   EXTREMITIES: 1+ pitting edema, warm without cyanosis
   NEUROLOGIC: Alert and appropriate.
   Labs / Radiology
   91 K/uL
   7.3 g/dL
   81 mg/dL
   2.5 mg/dL
   30 mEq/L
   3.4 mEq/L
   10 mg/dL
   106 mEq/L
   143 mEq/L
   22.4 %
   2.2 K/uL
        [image002.jpg]
                             [**2150-1-10**]  11:24 PM
                             [**2150-1-11**]  05:41 AM
                             [**2150-1-11**]  03:29 PM
                             [**2150-1-12**]  05:03 AM
                             [**2150-1-12**]  03:39 PM
                             [**2150-1-13**]  07:47 AM
                             [**2150-1-13**]  11:37 AM
                             [**2150-1-13**]  05:23 PM
                             [**2150-1-14**]  04:22 AM
   WBC
   2.9
   2.8
   3.5
   2.3
   2.6
   2.8
   2.2
   Hct
   20.6
   23.1
   27.4
   25.3
   28.0
   25.2
   22.4
   Plt
   65
   60
   96
   76
   90
   92
   91
   Cr
   3.0
   3.1
   4.2
   4.4
   4.5
   2.5
   TropT
   0.02
   0.02
   0.08
   0.06
   Glucose
   119
   74
   77
   126
   84
   81
   Other labs: PT / PTT / INR:34.9/31.8/3.6, CK / CKMB /
   Troponin-T:10//0.06, Alk Phos / T Bili:/0.4, Differential-Neuts:26.0 %,
   Band:4.0 %, Lymph:62.0 %, Mono:5.0 %, Eos:2.0 %, Lactic Acid:1.4
   mmol/L, LDH:443 IU/L, Ca++:7.8 mg/dL, Mg++:1.6 mg/dL, PO4:2.1 mg/dL
   Assessment and Plan
 ATRIAL FIBRILLATION (AFIB)
 ANEMIA, CHRONIC
 DEEP VENOUS THROMBOSIS (DVT), UPPER EXTREMITY
 SEPSIS WITHOUT ORGAN DYSFUNCTION
 RENAL FAILURE, END STAGE (END STAGE RENAL DISEASE, ESRD)
 SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)
   52 year old female with ESRD on HD, recent VRE bacteremia, CMV Viremia,
   SLE, initially admitted for possible VRE sepsis and now representing to
   the MICU with afib with RVR.  Overnight she had some rapid rate.
   #. Afib with RVR:  Patient with a history of paroxysmal atrial
   fibrillation, chronically anticoagulated with coumadin. INR has been
   therapeutic since [**1-5**].  Still in a rapid rate despite starting Digoxin
   - Confirm Digoxin dosing with renal as patient may need load (currently
   0.125mg PO 3x/week)
   - continue anticoagulation
   #. Sepsis: Patient initially presented with fevers, hypotension,
   tachycardia and a lactate of 4.8. She is chronically immunosuppressed
   and her presentation was initially concerning for sepsis. She was
   stared on PO vanc/[**Last Name (un) **]/dapto empirically. Her hypotension resolved
   after fluid administration and her lactate returned to [**Location 838**] levels.
   Infx work up has been (-) to date.
   - Continue Daptomycin per ID recs
   - f/u CMV Viral load
   - f/u blood cultures
   - cont Midodrine per home regimen
   #. Neutropenia: On admission WBC 4 and it has trended down throughout
   admission. Today it is 2.6, with a calculated ANC-780. Patient has
   remained afebrile. Likely due to linezolid as patient was taking as an
   outpatient.
   - cont to f/u counts
   - trend fever
   - CIS
   # ESRD on HD s/p failed transplant: Patient on TTS schedule. Renal is
   following.
   - cont nephrocaps
   - cont HD per schedule, last HD yesterday in ICU
   - cont Prednisone and Dapsone ppx
   # Venous thrombus: Patient with known complete thrombosis of the left
   AV graft, left cephalic and left subclavian veins, and partial
   thrombosis of left brachiocephalic vein with extension to SVC.  INR 3.7
   today.
   - Hold Coumadin until INR <3.
   # CMV viremia: Patinet has been treated with valganciclovir and
   followed by ID, but this has been stopped due to neutropenia.
   - f/u CMV viral load
   - patient is followed Dr. [**Last Name (STitle) 980**] as an outpatient
   #Anemia- Hct 25 on admission (baseline 27-30), currently mid 20s.
   Likely due to ESRD and anemia of chronic inflammation.  Trending
   downward.  Given Supratherapeutic INR, may represent bleed.
   - Check afternoon Hct
   - EPO with HD
   - Guaiac stools
   #Hyperglycemia-Pt has known elevated FS in setting of steroids
   - cont ISS
   # PPX: PPI, Coumadin  (Held today)
   # ACCESS: Left EJ, PIV
   # CODE:FULL
   # CONTACT: [**Name (NI) 430**] [**Name (NI) 8128**], sister [**Telephone/Fax (1) 10948**]
   # DISPO: Call out to Floor today
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   18 Gauge - [**2150-1-13**] 08:08 AM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint:
   24 Hour Events:
   HD in room overnight
   -Developed Afib with rapid rate to 120s-130s, controlled to 100s with
   Digoxin PO x1.  No hypotension
   - vancomycin and meropenem stopped given lack of clear indication
   - metoprolol changed to digoxin per recommendation of renal to better
   support BP
   Allergies:
   Bactrim Ds (Oral) (Sulfamethoxazole/Trimethoprim)
   Exfoliative [**Doctor Last Name **]
   Cellcept (Oral) (Mycophenolate Mofetil)
   Rash;
   Zosyn (Intraven) (Piperacillin Sodium/Tazobactam)
   Myelosuppressio
   Last dose of Antibiotics:
   Vancomycin - [**2150-1-12**] 06:29 AM
   Meropenem - [**2150-1-12**] 12:28 PM
   Infusions:
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2150-1-14**] 07:48 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**51**] AM
   Tmax: 36.9
C (98.4
   Tcurrent: 36.8
C (98.2
   HR: 100 (71 - 121) bpm
   BP: 95/61(67) {88/52(62) - 113/80(177)} mmHg
   RR: 15 (15 - 24) insp/min
   SpO2: 97%
   Heart rhythm: AF (Atrial Fibrillation)
             Total In:
                                                                    161 mL
                                                                     78 mL
   PO:
             TF:
   IVF:
                                                                    161 mL
                                                                     78 mL
   Blood products:
   Total out:
                                                                      0 mL
                                                                      0 mL
   Urine:
   NG:
   Stool:
   Drains:
   Balance:
                                                                    161 mL
                                                                     78 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 97%
   ABG: ///30/
   Physical Examination
   GEN: The patient is in no acute distress
   SKIN: Pale, No rashes or skin changes noted
   HEENT: Distended neck veins to mandible, neck supple, No
   lymphadenopathy in cervical, posterior, or supraclavicular chains
   noted.
   CHEST: Lungs with soft bibasilar crackles
   CARDIAC: reg rhythm, loud crisp sounding S2 over RUSB, [**1-31**] holosystolic
   murmur at left sternal border
   ABDOMEN: Non-distended, and soft without tenderness
   EXTREMITIES: 1+ pitting edema, warm without cyanosis
   NEUROLOGIC: Alert and appropriate.
   Labs / Radiology
   91 K/uL
   7.3 g/dL
   81 mg/dL
   2.5 mg/dL
   30 mEq/L
   3.4 mEq/L
   10 mg/dL
   106 mEq/L
   143 mEq/L
   22.4 %
   2.2 K/uL
        [image002.jpg]
                             [**2150-1-10**]  11:24 PM
                             [**2150-1-11**]  05:41 AM
                             [**2150-1-11**]  03:29 PM
                             [**2150-1-12**]  05:03 AM
                             [**2150-1-12**]  03:39 PM
                             [**2150-1-13**]  07:47 AM
                             [**2150-1-13**]  11:37 AM
                             [**2150-1-13**]  05:23 PM
                             [**2150-1-14**]  04:22 AM
   WBC
   2.9
   2.8
   3.5
   2.3
   2.6
   2.8
   2.2
   Hct
   20.6
   23.1
   27.4
   25.3
   28.0
   25.2
   22.4
   Plt
   65
   60
   96
   76
   90
   92
   91
   Cr
   3.0
   3.1
   4.2
   4.4
   4.5
   2.5
   TropT
   0.02
   0.02
   0.08
   0.06
   Glucose
   119
   74
   77
   126
   84
   81
   Other labs: PT / PTT / INR:34.9/31.8/3.6, CK / CKMB /
   Troponin-T:10//0.06, Alk Phos / T Bili:/0.4, Differential-Neuts:26.0 %,
   Band:4.0 %, Lymph:62.0 %, Mono:5.0 %, Eos:2.0 %, Lactic Acid:1.4
   mmol/L, LDH:443 IU/L, Ca++:7.8 mg/dL, Mg++:1.6 mg/dL, PO4:2.1 mg/dL
   Assessment and Plan
 ATRIAL FIBRILLATION (AFIB)
 ANEMIA, CHRONIC
 DEEP VENOUS THROMBOSIS (DVT), UPPER EXTREMITY
 SEPSIS WITHOUT ORGAN DYSFUNCTION
 RENAL FAILURE, END STAGE (END STAGE RENAL DISEASE, ESRD)
 SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)
   52 year old female with ESRD on HD, recent VRE bacteremia, CMV Viremia,
   SLE, initially admitted for possible VRE sepsis and now representing to
   the MICU with afib with RVR.  Overnight she had some rapid rate.
   #. Afib with RVR:  Patient with a history of paroxysmal atrial
   fibrillation, chronically anticoagulated with coumadin. INR has been
   therapeutic since [**1-5**].  Still in a rapid rate despite starting Digoxin
   - Confirm Digoxin dosing with renal as patient may need load (currently
   0.125mg PO 3x/week)
   - continue anticoagulation
   #. Sepsis: Patient initially presented with fevers, hypotension,
   tachycardia and a lactate of 4.8. She is chronically immunosuppressed
   and her presentation was initially concerning for sepsis. She was
   stared on PO vanc/[**Last Name (un) **]/dapto empirically. Her hypotension resolved
   after fluid administration and her lactate returned to [**Location 838**] levels.
   Infx work up has been (-) to date.
   - Continue Daptomycin per ID recs
   - f/u CMV Viral load
   - f/u blood cultures
   - cont Midodrine per home regimen
   #. Neutropenia: On admission WBC 4 and it has trended down throughout
   admission. Today it is 2.6, with a calculated ANC-780. Patient has
   remained afebrile. Likely due to linezolid as patient was taking as an
   outpatient.
   - cont to f/u counts
   - trend fever
   - CIS
   # ESRD on HD s/p failed transplant: Patient on TTS schedule. Renal is
   following.
   - cont nephrocaps
   - cont HD per schedule, last HD yesterday in ICU
   - cont Prednisone and Dapsone ppx
   # Venous thrombus: Patient with known complete thrombosis of the left
   AV graft, left cephalic and left subclavian veins, and partial
   thrombosis of left brachiocephalic vein with extension to SVC.  INR 3.7
   today.
   - Hold Coumadin until INR <3.
   # CMV viremia: Patinet has been treated with valganciclovir and
   followed by ID, but this has been stopped due to neutropenia.
   - f/u CMV viral load
   - patient is followed Dr. [**Last Name (STitle) 980**] as an outpatient
   #Anemia- Hct 25 on admission (baseline 27-30), currently mid 20s.
   Likely due to ESRD and anemia of chronic inflammation.  Trending
   downward.  Given Supratherapeutic INR, may represent bleed.
   - Check afternoon Hct
   - EPO with HD
   - Guaiac stools
   #Hyperglycemia-Pt has known elevated FS in setting of steroids
   - cont ISS
   # PPX: PPI, Coumadin  (Held today)
   # ACCESS: Left EJ, PIV
   # CODE:FULL
   # CONTACT: [**Name (NI) 430**] [**Name (NI) 8128**], sister [**Telephone/Fax (1) 10948**]
   # DISPO: Call out to Floor today
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   18 Gauge - [**2150-1-13**] 08:08 AM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the provided progress note, the patient is a 52-year-old female with a complex medical history, including end-stage renal disease (ESRD) on hemodialysis (HD), recent VRE bacteremia, CMV viremia, and systemic lupus erythematosus (SLE). She was admitted to the MICU with atrial fibrillation with rapid ventricular rate (AFIB) and sepsis without organ dysfunction.

The patient's current vital signs are:

* Temperature: 36.9°C (98.4°F)
* Heart rate: 100 beats per minute (bpm)
* Blood pressure: 95/61 mmHg
* Respiratory rate: 15 inspirations per minute (ins/min)
* Oxygen saturation: 97%

The patient has a history of paroxysmal atrial fibrillation and is chronically anticoagulated with coumadin, with an INR of 3.6. Despite starting digoxin, the patient's AFIB persists, and the digoxin dosing needs to be confirmed with renal consultation.

The patient's sepsis workup has been negative to date, and she is being continued on daptomycin per ID recommendations. The patient's CMV viral load and blood cultures need to be followed.

The patient has neutropenia, likely due to linezolid, and her WBC count is trending downward. She remains afebrile, and her ANC is 780.

The patient has ESRD on HD and is on a TTS schedule. Her renal function is being followed by renal consultation.

The patient has a history of deep venous thrombosis (DVT) and is on coumadin, which needs to be held until her INR is less than 3.

The patient has CMV viremia and is being followed by ID consultation. Her viral load needs to be followed.

The patient has anemia, likely due to ESRD and anemia of chronic inflammation. Her Hct is trending downward, and she may need to be transfused.

The patient has hyperglycemia, likely due to her known elevated fasting glucose in the setting of steroids.

Potential medical complications that can arise include:

1. AFIB with rapid ventricular rate: The patient's AFIB persists despite starting digoxin, and her digoxin dosing needs to be confirmed with renal consultation.
2. Sepsis: The patient's sepsis workup has been negative to date, but she needs to be continued on daptomycin per ID recommendations.
3. Neutropenia: The patient's WBC count is trending downward, and she remains afebrile, but her ANC is 780.
4. ESRD: The patient has ESRD on HD and is on a TTS schedule. Her renal function is being followed by renal consultation.
5. DVT: The patient has a history of DVT and is on coumadin, which needs to be held until her INR is less than 3.
6. CMV viremia: The patient has CMV viremia and is being followed by ID consultation. Her viral load needs to be followed.
7. Anemia: The patient has anemia, likely due to ESRD and anemia of chronic inflammation. Her Hct is trending downward, and she may need to be transfused.
8. Hyperglycemia: The patient has hyperglycemia, likely due to her known elevated fasting glucose in the setting of steroids.

In conclusion, the patient has a complex medical history and is being managed for AFIB, sepsis, neutropenia, ESRD, DVT, CMV viremia, anemia, and hyperglycemia. Her potential medical complications include AFIB with rapid ventricular rate, sepsis, neutropenia, ESRD, DVT, CMV viremia, anemia, and hyperglycemia."
151778.0,205979,2150-01-14 07:49:00,Physician ,Physician Resident Progress Note,"Chief Complaint:
   24 Hour Events:
   HD in room overnight
   -Developed Afib with rapid rate to 120s-130s, controlled to 100s with
   Digoxin PO x1.  No hypotension
   Allergies:
   Bactrim Ds (Oral) (Sulfamethoxazole/Trimethoprim)
   Exfoliative [**Doctor Last Name **]
   Cellcept (Oral) (Mycophenolate Mofetil)
   Rash;
   Zosyn (Intraven) (Piperacillin Sodium/Tazobactam)
   Myelosuppressio
   Last dose of Antibiotics:
   Vancomycin - [**2150-1-12**] 06:29 AM
   Meropenem - [**2150-1-12**] 12:28 PM
   Infusions:
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2150-1-14**] 07:48 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**51**] AM
   Tmax: 36.9
C (98.4
   Tcurrent: 36.8
C (98.2
   HR: 100 (71 - 121) bpm
   BP: 95/61(67) {88/52(62) - 113/80(177)} mmHg
   RR: 15 (15 - 24) insp/min
   SpO2: 97%
   Heart rhythm: AF (Atrial Fibrillation)
             Total In:
                                                                    161 mL
                                                                     78 mL
   PO:
             TF:
   IVF:
                                                                    161 mL
                                                                     78 mL
   Blood products:
   Total out:
                                                                      0 mL
                                                                      0 mL
   Urine:
   NG:
   Stool:
   Drains:
   Balance:
                                                                    161 mL
                                                                     78 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 97%
   ABG: ///30/
   Physical Examination
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   91 K/uL
   7.3 g/dL
   81 mg/dL
   2.5 mg/dL
   30 mEq/L
   3.4 mEq/L
   10 mg/dL
   106 mEq/L
   143 mEq/L
   22.4 %
   2.2 K/uL
        [image002.jpg]
                             [**2150-1-10**]  11:24 PM
                             [**2150-1-11**]  05:41 AM
                             [**2150-1-11**]  03:29 PM
                             [**2150-1-12**]  05:03 AM
                             [**2150-1-12**]  03:39 PM
                             [**2150-1-13**]  07:47 AM
                             [**2150-1-13**]  11:37 AM
                             [**2150-1-13**]  05:23 PM
                             [**2150-1-14**]  04:22 AM
   WBC
   2.9
   2.8
   3.5
   2.3
   2.6
   2.8
   2.2
   Hct
   20.6
   23.1
   27.4
   25.3
   28.0
   25.2
   22.4
   Plt
   65
   60
   96
   76
   90
   92
   91
   Cr
   3.0
   3.1
   4.2
   4.4
   4.5
   2.5
   TropT
   0.02
   0.02
   0.08
   0.06
   Glucose
   119
   74
   77
   126
   84
   81
   Other labs: PT / PTT / INR:34.9/31.8/3.6, CK / CKMB /
   Troponin-T:10//0.06, Alk Phos / T Bili:/0.4, Differential-Neuts:26.0 %,
   Band:4.0 %, Lymph:62.0 %, Mono:5.0 %, Eos:2.0 %, Lactic Acid:1.4
   mmol/L, LDH:443 IU/L, Ca++:7.8 mg/dL, Mg++:1.6 mg/dL, PO4:2.1 mg/dL
   Assessment and Plan
 ATRIAL FIBRILLATION (AFIB)
 ANEMIA, CHRONIC
 DEEP VENOUS THROMBOSIS (DVT), UPPER EXTREMITY
 SEPSIS WITHOUT ORGAN DYSFUNCTION
 RENAL FAILURE, END STAGE (END STAGE RENAL DISEASE, ESRD)
 SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   18 Gauge - [**2150-1-13**] 08:08 AM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint:
   24 Hour Events:
   HD in room overnight
   -Developed Afib with rapid rate to 120s-130s, controlled to 100s with
   Digoxin PO x1.  No hypotension
   Allergies:
   Bactrim Ds (Oral) (Sulfamethoxazole/Trimethoprim)
   Exfoliative [**Doctor Last Name **]
   Cellcept (Oral) (Mycophenolate Mofetil)
   Rash;
   Zosyn (Intraven) (Piperacillin Sodium/Tazobactam)
   Myelosuppressio
   Last dose of Antibiotics:
   Vancomycin - [**2150-1-12**] 06:29 AM
   Meropenem - [**2150-1-12**] 12:28 PM
   Infusions:
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2150-1-14**] 07:48 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**51**] AM
   Tmax: 36.9
C (98.4
   Tcurrent: 36.8
C (98.2
   HR: 100 (71 - 121) bpm
   BP: 95/61(67) {88/52(62) - 113/80(177)} mmHg
   RR: 15 (15 - 24) insp/min
   SpO2: 97%
   Heart rhythm: AF (Atrial Fibrillation)
             Total In:
                                                                    161 mL
                                                                     78 mL
   PO:
             TF:
   IVF:
                                                                    161 mL
                                                                     78 mL
   Blood products:
   Total out:
                                                                      0 mL
                                                                      0 mL
   Urine:
   NG:
   Stool:
   Drains:
   Balance:
                                                                    161 mL
                                                                     78 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 97%
   ABG: ///30/
   Physical Examination
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   91 K/uL
   7.3 g/dL
   81 mg/dL
   2.5 mg/dL
   30 mEq/L
   3.4 mEq/L
   10 mg/dL
   106 mEq/L
   143 mEq/L
   22.4 %
   2.2 K/uL
        [image002.jpg]
                             [**2150-1-10**]  11:24 PM
                             [**2150-1-11**]  05:41 AM
                             [**2150-1-11**]  03:29 PM
                             [**2150-1-12**]  05:03 AM
                             [**2150-1-12**]  03:39 PM
                             [**2150-1-13**]  07:47 AM
                             [**2150-1-13**]  11:37 AM
                             [**2150-1-13**]  05:23 PM
                             [**2150-1-14**]  04:22 AM
   WBC
   2.9
   2.8
   3.5
   2.3
   2.6
   2.8
   2.2
   Hct
   20.6
   23.1
   27.4
   25.3
   28.0
   25.2
   22.4
   Plt
   65
   60
   96
   76
   90
   92
   91
   Cr
   3.0
   3.1
   4.2
   4.4
   4.5
   2.5
   TropT
   0.02
   0.02
   0.08
   0.06
   Glucose
   119
   74
   77
   126
   84
   81
   Other labs: PT / PTT / INR:34.9/31.8/3.6, CK / CKMB /
   Troponin-T:10//0.06, Alk Phos / T Bili:/0.4, Differential-Neuts:26.0 %,
   Band:4.0 %, Lymph:62.0 %, Mono:5.0 %, Eos:2.0 %, Lactic Acid:1.4
   mmol/L, LDH:443 IU/L, Ca++:7.8 mg/dL, Mg++:1.6 mg/dL, PO4:2.1 mg/dL
   Assessment and Plan
 ATRIAL FIBRILLATION (AFIB)
 ANEMIA, CHRONIC
 DEEP VENOUS THROMBOSIS (DVT), UPPER EXTREMITY
 SEPSIS WITHOUT ORGAN DYSFUNCTION
 RENAL FAILURE, END STAGE (END STAGE RENAL DISEASE, ESRD)
 SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   18 Gauge - [**2150-1-13**] 08:08 AM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Summary:

The patient is a 24-hour-old ICU admission with a history of atrial fibrillation, controlled with digoxin. The patient developed a rapid rate of 120-130 beats per minute, which was controlled with digoxin. The patient has a history of chronic anemia, deep vein thrombosis, sepsis without organ dysfunction, end-stage renal disease, and systemic lupus erythematosus.

The patient's vital signs are stable, with a temperature of 36.9°C (98.4°F), heart rate of 100 beats per minute, and blood pressure of 95/61 mmHg. The patient is receiving oxygen therapy and has a SpO2 of 97%. The patient's respiratory support is limited to oxygen therapy, and there is no evidence of respiratory distress.

The patient's laboratory results show anemia, with a hemoglobin level of 7.3 g/dL, and a white blood cell count of 2.9 K/uL. The patient's electrolyte levels are within normal limits, with the exception of a slightly elevated potassium level of 4.5 mEq/L.

The patient's plan includes continued monitoring of atrial fibrillation, management of anemia, and treatment of sepsis without organ dysfunction. The patient will also receive prophylaxis for deep vein thrombosis, stress ulcer, and ventilator-associated pneumonia.

Potential medical complications that can arise:

1. Cardiac arrhythmias: The patient's history of atrial fibrillation and the presence of digoxin therapy increase the risk of cardiac arrhythmias.
2. Infection: The patient's history of sepsis without organ dysfunction and the presence of central lines and urinary catheters increase the risk of infection.
3. Bleeding: The patient's history of anemia and the presence of anticoagulation therapy increase the risk of bleeding.
4. Renal failure: The patient's history of end-stage renal disease and the presence of chronic anemia increase the risk of renal failure.
5. Respiratory failure: The patient's history of sepsis without organ dysfunction and the presence of respiratory support increase the risk of respiratory failure.
6. Neurological complications: The patient's history of systemic lupus erythematosus and the presence of central nervous system symptoms increase the risk of neurological complications."
151778.0,205979,2150-01-14 07:49:00,Physician ,Physician Resident Progress Note,"Chief Complaint:
   24 Hour Events:
   HD in room overnight
   -Developed Afib with rapid rate to 120s-130s, controlled to 100s with
   Digoxin PO x1.  No hypotension
   Allergies:
   Bactrim Ds (Oral) (Sulfamethoxazole/Trimethoprim)
   Exfoliative [**Doctor Last Name **]
   Cellcept (Oral) (Mycophenolate Mofetil)
   Rash;
   Zosyn (Intraven) (Piperacillin Sodium/Tazobactam)
   Myelosuppressio
   Last dose of Antibiotics:
   Vancomycin - [**2150-1-12**] 06:29 AM
   Meropenem - [**2150-1-12**] 12:28 PM
   Infusions:
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2150-1-14**] 07:48 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**51**] AM
   Tmax: 36.9
C (98.4
   Tcurrent: 36.8
C (98.2
   HR: 100 (71 - 121) bpm
   BP: 95/61(67) {88/52(62) - 113/80(177)} mmHg
   RR: 15 (15 - 24) insp/min
   SpO2: 97%
   Heart rhythm: AF (Atrial Fibrillation)
             Total In:
                                                                    161 mL
                                                                     78 mL
   PO:
             TF:
   IVF:
                                                                    161 mL
                                                                     78 mL
   Blood products:
   Total out:
                                                                      0 mL
                                                                      0 mL
   Urine:
   NG:
   Stool:
   Drains:
   Balance:
                                                                    161 mL
                                                                     78 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 97%
   ABG: ///30/
   Physical Examination
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   91 K/uL
   7.3 g/dL
   81 mg/dL
   2.5 mg/dL
   30 mEq/L
   3.4 mEq/L
   10 mg/dL
   106 mEq/L
   143 mEq/L
   22.4 %
   2.2 K/uL
        [image002.jpg]
                             [**2150-1-10**]  11:24 PM
                             [**2150-1-11**]  05:41 AM
                             [**2150-1-11**]  03:29 PM
                             [**2150-1-12**]  05:03 AM
                             [**2150-1-12**]  03:39 PM
                             [**2150-1-13**]  07:47 AM
                             [**2150-1-13**]  11:37 AM
                             [**2150-1-13**]  05:23 PM
                             [**2150-1-14**]  04:22 AM
   WBC
   2.9
   2.8
   3.5
   2.3
   2.6
   2.8
   2.2
   Hct
   20.6
   23.1
   27.4
   25.3
   28.0
   25.2
   22.4
   Plt
   65
   60
   96
   76
   90
   92
   91
   Cr
   3.0
   3.1
   4.2
   4.4
   4.5
   2.5
   TropT
   0.02
   0.02
   0.08
   0.06
   Glucose
   119
   74
   77
   126
   84
   81
   Other labs: PT / PTT / INR:34.9/31.8/3.6, CK / CKMB /
   Troponin-T:10//0.06, Alk Phos / T Bili:/0.4, Differential-Neuts:26.0 %,
   Band:4.0 %, Lymph:62.0 %, Mono:5.0 %, Eos:2.0 %, Lactic Acid:1.4
   mmol/L, LDH:443 IU/L, Ca++:7.8 mg/dL, Mg++:1.6 mg/dL, PO4:2.1 mg/dL
   Assessment and Plan
 ATRIAL FIBRILLATION (AFIB)
 ANEMIA, CHRONIC
 DEEP VENOUS THROMBOSIS (DVT), UPPER EXTREMITY
 SEPSIS WITHOUT ORGAN DYSFUNCTION
 RENAL FAILURE, END STAGE (END STAGE RENAL DISEASE, ESRD)
 SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)
   52 year old female with ESRD on HD, recent VRE bacteremia, CMV Viremia,
   SLE, initially admitted for possible VRE sepsis and now representing to
   the MICU with afib with RVR.
   .
   #. Afib with RVR:  Patient with a history of paroxysmal atrial
   fibrillation, chronically anticoagulated with coumadin. INR has been
   therapeutic since [**1-5**], previously subtherapeutic.  Given excellent
   mentation, currently improving hemodynamic parameters including
   decreasing heart rate, no indication for urgent cardioversion now and
   has not been anticoagulated for long enough anyway.  Has received a
   total 10 mg IV metoprolol and 20 mg IV diltiazem, 2.5L IVF as well as
   10 mg midodrine.  Previously on no rate control agents. Differential
   for cause of episode of RVR includes stress of recent infection, volume
   depletion.  Patient flipped back into NSR in the 70s on arrival to the
   ICU.
   - start metoprolol tartrate 25 mg PO bid
   - f/u cardiac enzymes
   - repeat EKG
   - continue anticoagulation
   .
   #. Sepsis: Patient initially presented with fevers, hyotension,
   tachycardia and a lactate of 4.8. She is chronically immunosuppressed
   and her presentation was initially concerning for sepsis. She was
   stared on PO vanc/[**Last Name (un) **]/dapto empirically. Her hypotension resolved
   after fluid administration and her lactate returned to [**Location 838**] levels.
   Infx work up has been (-) to date.
   - consult ID about abx regimen
   - d/c vancomycin (C. diff negative)
   - f/u CMV Viral load
   - f/u blood cultures
   - cont Midodrine per home regimen
   .
   #. Neutropenia: On admission WBC 4 and it has trended down throughout
   admission. Today it is 2.6, with a calculated ANC-780. Patient has
   remained afebrile. Likely due to linezolid as patient was taking as an
   outpatient.
   - cont to f/u counts
   - trend fever
   - CIS
   .
   # ESRD on HD s/p failed transplant: Patient on TTS schedule. Renal is
   following.
   - cont nephrocaps
   - cont HD - spoke with renal fellow, will be done today in ICU
   - cont Prednisone and Dapsone ppx
   .
   # Venous thrombus: Patient with known complete thrombosis of the left
   AV graft, left cephalic and left subclavian veins, and partial
   thrombosis of left brachiocephalic vein with extension to SVC.
   - cont coumadin for goal INR [**12-31**]
   .
   # CMV viremia: Patinet has been treated with valganciclovir and
   followed by ID, but this has been stopped due to neutropenia.
   - f/u CMV viral load
   - patient is followed Dr. [**Last Name (STitle) 980**] as an outpatient
   .
   #Anemia- Hct 25 on admission (baseline 27-30), currently mid 20s.
   Likely due to ESRD and anemia of chronic inflammation.
   - f/u daily CBC
   - EPO with HD
   .
   #Hyperglycemia-Pt has known elevated FS in setting of steroids
   - cont ISS
   .
   # PPX: PPI, Coumadin
   # ACCESS: Left EJ, PIV
   # CODE:FULL
   # CONTACT: [**Name (NI) 430**] [**Name (NI) 8128**], sister [**Telephone/Fax (1) 10948**]
   # DISPO: pending above
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   18 Gauge - [**2150-1-13**] 08:08 AM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint:
   24 Hour Events:
   HD in room overnight
   -Developed Afib with rapid rate to 120s-130s, controlled to 100s with
   Digoxin PO x1.  No hypotension
   Allergies:
   Bactrim Ds (Oral) (Sulfamethoxazole/Trimethoprim)
   Exfoliative [**Doctor Last Name **]
   Cellcept (Oral) (Mycophenolate Mofetil)
   Rash;
   Zosyn (Intraven) (Piperacillin Sodium/Tazobactam)
   Myelosuppressio
   Last dose of Antibiotics:
   Vancomycin - [**2150-1-12**] 06:29 AM
   Meropenem - [**2150-1-12**] 12:28 PM
   Infusions:
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2150-1-14**] 07:48 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**51**] AM
   Tmax: 36.9
C (98.4
   Tcurrent: 36.8
C (98.2
   HR: 100 (71 - 121) bpm
   BP: 95/61(67) {88/52(62) - 113/80(177)} mmHg
   RR: 15 (15 - 24) insp/min
   SpO2: 97%
   Heart rhythm: AF (Atrial Fibrillation)
             Total In:
                                                                    161 mL
                                                                     78 mL
   PO:
             TF:
   IVF:
                                                                    161 mL
                                                                     78 mL
   Blood products:
   Total out:
                                                                      0 mL
                                                                      0 mL
   Urine:
   NG:
   Stool:
   Drains:
   Balance:
                                                                    161 mL
                                                                     78 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 97%
   ABG: ///30/
   Physical Examination
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   91 K/uL
   7.3 g/dL
   81 mg/dL
   2.5 mg/dL
   30 mEq/L
   3.4 mEq/L
   10 mg/dL
   106 mEq/L
   143 mEq/L
   22.4 %
   2.2 K/uL
        [image002.jpg]
                             [**2150-1-10**]  11:24 PM
                             [**2150-1-11**]  05:41 AM
                             [**2150-1-11**]  03:29 PM
                             [**2150-1-12**]  05:03 AM
                             [**2150-1-12**]  03:39 PM
                             [**2150-1-13**]  07:47 AM
                             [**2150-1-13**]  11:37 AM
                             [**2150-1-13**]  05:23 PM
                             [**2150-1-14**]  04:22 AM
   WBC
   2.9
   2.8
   3.5
   2.3
   2.6
   2.8
   2.2
   Hct
   20.6
   23.1
   27.4
   25.3
   28.0
   25.2
   22.4
   Plt
   65
   60
   96
   76
   90
   92
   91
   Cr
   3.0
   3.1
   4.2
   4.4
   4.5
   2.5
   TropT
   0.02
   0.02
   0.08
   0.06
   Glucose
   119
   74
   77
   126
   84
   81
   Other labs: PT / PTT / INR:34.9/31.8/3.6, CK / CKMB /
   Troponin-T:10//0.06, Alk Phos / T Bili:/0.4, Differential-Neuts:26.0 %,
   Band:4.0 %, Lymph:62.0 %, Mono:5.0 %, Eos:2.0 %, Lactic Acid:1.4
   mmol/L, LDH:443 IU/L, Ca++:7.8 mg/dL, Mg++:1.6 mg/dL, PO4:2.1 mg/dL
   Assessment and Plan
 ATRIAL FIBRILLATION (AFIB)
 ANEMIA, CHRONIC
 DEEP VENOUS THROMBOSIS (DVT), UPPER EXTREMITY
 SEPSIS WITHOUT ORGAN DYSFUNCTION
 RENAL FAILURE, END STAGE (END STAGE RENAL DISEASE, ESRD)
 SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)
   52 year old female with ESRD on HD, recent VRE bacteremia, CMV Viremia,
   SLE, initially admitted for possible VRE sepsis and now representing to
   the MICU with afib with RVR.
   .
   #. Afib with RVR:  Patient with a history of paroxysmal atrial
   fibrillation, chronically anticoagulated with coumadin. INR has been
   therapeutic since [**1-5**], previously subtherapeutic.  Given excellent
   mentation, currently improving hemodynamic parameters including
   decreasing heart rate, no indication for urgent cardioversion now and
   has not been anticoagulated for long enough anyway.  Has received a
   total 10 mg IV metoprolol and 20 mg IV diltiazem, 2.5L IVF as well as
   10 mg midodrine.  Previously on no rate control agents. Differential
   for cause of episode of RVR includes stress of recent infection, volume
   depletion.  Patient flipped back into NSR in the 70s on arrival to the
   ICU.
   - start metoprolol tartrate 25 mg PO bid
   - f/u cardiac enzymes
   - repeat EKG
   - continue anticoagulation
   .
   #. Sepsis: Patient initially presented with fevers, hyotension,
   tachycardia and a lactate of 4.8. She is chronically immunosuppressed
   and her presentation was initially concerning for sepsis. She was
   stared on PO vanc/[**Last Name (un) **]/dapto empirically. Her hypotension resolved
   after fluid administration and her lactate returned to [**Location 838**] levels.
   Infx work up has been (-) to date.
   - consult ID about abx regimen
   - d/c vancomycin (C. diff negative)
   - f/u CMV Viral load
   - f/u blood cultures
   - cont Midodrine per home regimen
   .
   #. Neutropenia: On admission WBC 4 and it has trended down throughout
   admission. Today it is 2.6, with a calculated ANC-780. Patient has
   remained afebrile. Likely due to linezolid as patient was taking as an
   outpatient.
   - cont to f/u counts
   - trend fever
   - CIS
   .
   # ESRD on HD s/p failed transplant: Patient on TTS schedule. Renal is
   following.
   - cont nephrocaps
   - cont HD - spoke with renal fellow, will be done today in ICU
   - cont Prednisone and Dapsone ppx
   .
   # Venous thrombus: Patient with known complete thrombosis of the left
   AV graft, left cephalic and left subclavian veins, and partial
   thrombosis of left brachiocephalic vein with extension to SVC.
   - cont coumadin for goal INR [**12-31**]
   .
   # CMV viremia: Patinet has been treated with valganciclovir and
   followed by ID, but this has been stopped due to neutropenia.
   - f/u CMV viral load
   - patient is followed Dr. [**Last Name (STitle) 980**] as an outpatient
   .
   #Anemia- Hct 25 on admission (baseline 27-30), currently mid 20s.
   Likely due to ESRD and anemia of chronic inflammation.
   - f/u daily CBC
   - EPO with HD
   .
   #Hyperglycemia-Pt has known elevated FS in setting of steroids
   - cont ISS
   .
   # PPX: PPI, Coumadin
   # ACCESS: Left EJ, PIV
   # CODE:FULL
   # CONTACT: [**Name (NI) 430**] [**Name (NI) 8128**], sister [**Telephone/Fax (1) 10948**]
   # DISPO: pending above
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   18 Gauge - [**2150-1-13**] 08:08 AM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the provided progress note, the patient is a 52-year-old female with end-stage renal disease (ESRD) on hemodialysis (HD), recent VRE bacteremia, CMV viremia, and systemic lupus erythematosus (SLE). She was admitted to the medical intensive care unit (MICU) with atrial fibrillation (AF) with rapid ventricular rate (RVR).

The patient's vital signs are stable, with a heart rate of 100 beats per minute, blood pressure of 95/61 mmHg, and oxygen saturation of 97%. She has a temperature of 36.8°C (98.2°F) and a respiratory rate of 15 breaths per minute.

The patient's laboratory results show:

* Hemoglobin (Hb) level of 7.3 g/dL
* White blood cell (WBC) count of 2.6 x 10^9/L
* Platelet count of 91 x 10^9/L
* Creatinine (Cr) level of 3.0 mg/dL
* Troponin-T level of 0.02 ng/mL
* Lactic acid level of 1.4 mmol/L
* LDH level of 443 IU/L
* Calcium (Ca) level of 7.8 mg/dL
* Magnesium (Mg) level of 1.6 mg/dL
* Phosphate (PO4) level of 2.1 mg/dL

The patient's medical conditions include:

* Atrial fibrillation (AF) with RVR
* Anemia, chronic
* Deep venous thrombosis (DVT), upper extremity
* Sepsis without organ dysfunction
* Renal failure, end-stage (ESRD)
* Systemic lupus erythematosus (SLE)

The patient's treatment plan includes:

* Start metoprolol tartrate 25 mg PO bid for AF
* Continue anticoagulation with coumadin
* Consult ID about antibiotic regimen
* Discontinue vancomycin (C. diff negative)
* Follow CMV viral load
* Follow blood cultures
* Continue midodrine per home regimen
* Continue nephrocaps
* Continue HD
* Continue prednisone and dapsone prophylaxis
* Continue coumadin for goal INR 12-31
* Follow CMV viral load
* Patient is followed by Dr. [**Last Name (STitle) 980**] as an outpatient

Potential medical complications that can arise from the patient's conditions include:

* Cardiac arrhythmias, such as atrial flutter or ventricular tachycardia, due to AF
* Cardiac failure, due to decreased cardiac function
* Renal failure, due to ESRD
* Infection, due to chronic immunosuppression and sepsis
* Bleeding, due to anticoagulation therapy
* Thrombocytopenia, due to bone marrow suppression
* Anemia, due to chronic inflammation and ESRD
* Hyperglycemia, due to steroids and ESRD
* Hypocalcemia, due to chronic kidney disease
* Hyperphosphatemia, due to chronic kidney disease

It is essential to closely monitor the patient's vital signs, laboratory results, and treatment plan to prevent and manage these potential complications."
151778.0,205979,2150-01-14 07:49:00,Physician ,Physician Resident Progress Note,"Chief Complaint:
   24 Hour Events:
   HD in room overnight
   -Developed Afib with rapid rate to 120s-130s, controlled to 100s with
   Digoxin PO x1.  No hypotension
   - vancomycin and meropenem stopped given lack of clear indication
   - metoprolol changed to digoxin per recommendation of renal to better
   support BP
   Allergies:
   Bactrim Ds (Oral) (Sulfamethoxazole/Trimethoprim)
   Exfoliative [**Doctor Last Name **]
   Cellcept (Oral) (Mycophenolate Mofetil)
   Rash;
   Zosyn (Intraven) (Piperacillin Sodium/Tazobactam)
   Myelosuppressio
   Last dose of Antibiotics:
   Vancomycin - [**2150-1-12**] 06:29 AM
   Meropenem - [**2150-1-12**] 12:28 PM
   Infusions:
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2150-1-14**] 07:48 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**51**] AM
   Tmax: 36.9
C (98.4
   Tcurrent: 36.8
C (98.2
   HR: 100 (71 - 121) bpm
   BP: 95/61(67) {88/52(62) - 113/80(177)} mmHg
   RR: 15 (15 - 24) insp/min
   SpO2: 97%
   Heart rhythm: AF (Atrial Fibrillation)
             Total In:
                                                                    161 mL
                                                                     78 mL
   PO:
             TF:
   IVF:
                                                                    161 mL
                                                                     78 mL
   Blood products:
   Total out:
                                                                      0 mL
                                                                      0 mL
   Urine:
   NG:
   Stool:
   Drains:
   Balance:
                                                                    161 mL
                                                                     78 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 97%
   ABG: ///30/
   Physical Examination
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   91 K/uL
   7.3 g/dL
   81 mg/dL
   2.5 mg/dL
   30 mEq/L
   3.4 mEq/L
   10 mg/dL
   106 mEq/L
   143 mEq/L
   22.4 %
   2.2 K/uL
        [image002.jpg]
                             [**2150-1-10**]  11:24 PM
                             [**2150-1-11**]  05:41 AM
                             [**2150-1-11**]  03:29 PM
                             [**2150-1-12**]  05:03 AM
                             [**2150-1-12**]  03:39 PM
                             [**2150-1-13**]  07:47 AM
                             [**2150-1-13**]  11:37 AM
                             [**2150-1-13**]  05:23 PM
                             [**2150-1-14**]  04:22 AM
   WBC
   2.9
   2.8
   3.5
   2.3
   2.6
   2.8
   2.2
   Hct
   20.6
   23.1
   27.4
   25.3
   28.0
   25.2
   22.4
   Plt
   65
   60
   96
   76
   90
   92
   91
   Cr
   3.0
   3.1
   4.2
   4.4
   4.5
   2.5
   TropT
   0.02
   0.02
   0.08
   0.06
   Glucose
   119
   74
   77
   126
   84
   81
   Other labs: PT / PTT / INR:34.9/31.8/3.6, CK / CKMB /
   Troponin-T:10//0.06, Alk Phos / T Bili:/0.4, Differential-Neuts:26.0 %,
   Band:4.0 %, Lymph:62.0 %, Mono:5.0 %, Eos:2.0 %, Lactic Acid:1.4
   mmol/L, LDH:443 IU/L, Ca++:7.8 mg/dL, Mg++:1.6 mg/dL, PO4:2.1 mg/dL
   Assessment and Plan
 ATRIAL FIBRILLATION (AFIB)
 ANEMIA, CHRONIC
 DEEP VENOUS THROMBOSIS (DVT), UPPER EXTREMITY
 SEPSIS WITHOUT ORGAN DYSFUNCTION
 RENAL FAILURE, END STAGE (END STAGE RENAL DISEASE, ESRD)
 SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)
   52 year old female with ESRD on HD, recent VRE bacteremia, CMV Viremia,
   SLE, initially admitted for possible VRE sepsis and now representing to
   the MICU with afib with RVR.
   .
   #. Afib with RVR:  Patient with a history of paroxysmal atrial
   fibrillation, chronically anticoagulated with coumadin. INR has been
   therapeutic since [**1-5**], previously subtherapeutic.  Given excellent
   mentation, currently improving hemodynamic parameters including
   decreasing heart rate, no indication for urgent cardioversion now and
   has not been anticoagulated for long enough anyway.  Has received a
   total 10 mg IV metoprolol and 20 mg IV diltiazem, 2.5L IVF as well as
   10 mg midodrine.  Previously on no rate control agents. Differential
   for cause of episode of RVR includes stress of recent infection, volume
   depletion.  Patient flipped back into NSR in the 70s on arrival to the
   ICU.
   - start metoprolol tartrate 25 mg PO bid
   - f/u cardiac enzymes
   - repeat EKG
   - continue anticoagulation
   .
   #. Sepsis: Patient initially presented with fevers, hyotension,
   tachycardia and a lactate of 4.8. She is chronically immunosuppressed
   and her presentation was initially concerning for sepsis. She was
   stared on PO vanc/[**Last Name (un) **]/dapto empirically. Her hypotension resolved
   after fluid administration and her lactate returned to [**Location 838**] levels.
   Infx work up has been (-) to date.
   - consult ID about abx regimen
   - d/c vancomycin (C. diff negative)
   - f/u CMV Viral load
   - f/u blood cultures
   - cont Midodrine per home regimen
   .
   #. Neutropenia: On admission WBC 4 and it has trended down throughout
   admission. Today it is 2.6, with a calculated ANC-780. Patient has
   remained afebrile. Likely due to linezolid as patient was taking as an
   outpatient.
   - cont to f/u counts
   - trend fever
   - CIS
   .
   # ESRD on HD s/p failed transplant: Patient on TTS schedule. Renal is
   following.
   - cont nephrocaps
   - cont HD - spoke with renal fellow, will be done today in ICU
   - cont Prednisone and Dapsone ppx
   .
   # Venous thrombus: Patient with known complete thrombosis of the left
   AV graft, left cephalic and left subclavian veins, and partial
   thrombosis of left brachiocephalic vein with extension to SVC.
   - cont coumadin for goal INR [**12-31**]
   .
   # CMV viremia: Patinet has been treated with valganciclovir and
   followed by ID, but this has been stopped due to neutropenia.
   - f/u CMV viral load
   - patient is followed Dr. [**Last Name (STitle) 980**] as an outpatient
   .
   #Anemia- Hct 25 on admission (baseline 27-30), currently mid 20s.
   Likely due to ESRD and anemia of chronic inflammation.
   - f/u daily CBC
   - EPO with HD
   .
   #Hyperglycemia-Pt has known elevated FS in setting of steroids
   - cont ISS
   .
   # PPX: PPI, Coumadin
   # ACCESS: Left EJ, PIV
   # CODE:FULL
   # CONTACT: [**Name (NI) 430**] [**Name (NI) 8128**], sister [**Telephone/Fax (1) 10948**]
   # DISPO: pending above
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   18 Gauge - [**2150-1-13**] 08:08 AM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint:
   24 Hour Events:
   HD in room overnight
   -Developed Afib with rapid rate to 120s-130s, controlled to 100s with
   Digoxin PO x1.  No hypotension
   - vancomycin and meropenem stopped given lack of clear indication
   - metoprolol changed to digoxin per recommendation of renal to better
   support BP
   Allergies:
   Bactrim Ds (Oral) (Sulfamethoxazole/Trimethoprim)
   Exfoliative [**Doctor Last Name **]
   Cellcept (Oral) (Mycophenolate Mofetil)
   Rash;
   Zosyn (Intraven) (Piperacillin Sodium/Tazobactam)
   Myelosuppressio
   Last dose of Antibiotics:
   Vancomycin - [**2150-1-12**] 06:29 AM
   Meropenem - [**2150-1-12**] 12:28 PM
   Infusions:
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2150-1-14**] 07:48 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**51**] AM
   Tmax: 36.9
C (98.4
   Tcurrent: 36.8
C (98.2
   HR: 100 (71 - 121) bpm
   BP: 95/61(67) {88/52(62) - 113/80(177)} mmHg
   RR: 15 (15 - 24) insp/min
   SpO2: 97%
   Heart rhythm: AF (Atrial Fibrillation)
             Total In:
                                                                    161 mL
                                                                     78 mL
   PO:
             TF:
   IVF:
                                                                    161 mL
                                                                     78 mL
   Blood products:
   Total out:
                                                                      0 mL
                                                                      0 mL
   Urine:
   NG:
   Stool:
   Drains:
   Balance:
                                                                    161 mL
                                                                     78 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 97%
   ABG: ///30/
   Physical Examination
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   91 K/uL
   7.3 g/dL
   81 mg/dL
   2.5 mg/dL
   30 mEq/L
   3.4 mEq/L
   10 mg/dL
   106 mEq/L
   143 mEq/L
   22.4 %
   2.2 K/uL
        [image002.jpg]
                             [**2150-1-10**]  11:24 PM
                             [**2150-1-11**]  05:41 AM
                             [**2150-1-11**]  03:29 PM
                             [**2150-1-12**]  05:03 AM
                             [**2150-1-12**]  03:39 PM
                             [**2150-1-13**]  07:47 AM
                             [**2150-1-13**]  11:37 AM
                             [**2150-1-13**]  05:23 PM
                             [**2150-1-14**]  04:22 AM
   WBC
   2.9
   2.8
   3.5
   2.3
   2.6
   2.8
   2.2
   Hct
   20.6
   23.1
   27.4
   25.3
   28.0
   25.2
   22.4
   Plt
   65
   60
   96
   76
   90
   92
   91
   Cr
   3.0
   3.1
   4.2
   4.4
   4.5
   2.5
   TropT
   0.02
   0.02
   0.08
   0.06
   Glucose
   119
   74
   77
   126
   84
   81
   Other labs: PT / PTT / INR:34.9/31.8/3.6, CK / CKMB /
   Troponin-T:10//0.06, Alk Phos / T Bili:/0.4, Differential-Neuts:26.0 %,
   Band:4.0 %, Lymph:62.0 %, Mono:5.0 %, Eos:2.0 %, Lactic Acid:1.4
   mmol/L, LDH:443 IU/L, Ca++:7.8 mg/dL, Mg++:1.6 mg/dL, PO4:2.1 mg/dL
   Assessment and Plan
 ATRIAL FIBRILLATION (AFIB)
 ANEMIA, CHRONIC
 DEEP VENOUS THROMBOSIS (DVT), UPPER EXTREMITY
 SEPSIS WITHOUT ORGAN DYSFUNCTION
 RENAL FAILURE, END STAGE (END STAGE RENAL DISEASE, ESRD)
 SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)
   52 year old female with ESRD on HD, recent VRE bacteremia, CMV Viremia,
   SLE, initially admitted for possible VRE sepsis and now representing to
   the MICU with afib with RVR.
   .
   #. Afib with RVR:  Patient with a history of paroxysmal atrial
   fibrillation, chronically anticoagulated with coumadin. INR has been
   therapeutic since [**1-5**], previously subtherapeutic.  Given excellent
   mentation, currently improving hemodynamic parameters including
   decreasing heart rate, no indication for urgent cardioversion now and
   has not been anticoagulated for long enough anyway.  Has received a
   total 10 mg IV metoprolol and 20 mg IV diltiazem, 2.5L IVF as well as
   10 mg midodrine.  Previously on no rate control agents. Differential
   for cause of episode of RVR includes stress of recent infection, volume
   depletion.  Patient flipped back into NSR in the 70s on arrival to the
   ICU.
   - start metoprolol tartrate 25 mg PO bid
   - f/u cardiac enzymes
   - repeat EKG
   - continue anticoagulation
   .
   #. Sepsis: Patient initially presented with fevers, hyotension,
   tachycardia and a lactate of 4.8. She is chronically immunosuppressed
   and her presentation was initially concerning for sepsis. She was
   stared on PO vanc/[**Last Name (un) **]/dapto empirically. Her hypotension resolved
   after fluid administration and her lactate returned to [**Location 838**] levels.
   Infx work up has been (-) to date.
   - consult ID about abx regimen
   - d/c vancomycin (C. diff negative)
   - f/u CMV Viral load
   - f/u blood cultures
   - cont Midodrine per home regimen
   .
   #. Neutropenia: On admission WBC 4 and it has trended down throughout
   admission. Today it is 2.6, with a calculated ANC-780. Patient has
   remained afebrile. Likely due to linezolid as patient was taking as an
   outpatient.
   - cont to f/u counts
   - trend fever
   - CIS
   .
   # ESRD on HD s/p failed transplant: Patient on TTS schedule. Renal is
   following.
   - cont nephrocaps
   - cont HD - spoke with renal fellow, will be done today in ICU
   - cont Prednisone and Dapsone ppx
   .
   # Venous thrombus: Patient with known complete thrombosis of the left
   AV graft, left cephalic and left subclavian veins, and partial
   thrombosis of left brachiocephalic vein with extension to SVC.
   - cont coumadin for goal INR [**12-31**]
   .
   # CMV viremia: Patinet has been treated with valganciclovir and
   followed by ID, but this has been stopped due to neutropenia.
   - f/u CMV viral load
   - patient is followed Dr. [**Last Name (STitle) 980**] as an outpatient
   .
   #Anemia- Hct 25 on admission (baseline 27-30), currently mid 20s.
   Likely due to ESRD and anemia of chronic inflammation.
   - f/u daily CBC
   - EPO with HD
   .
   #Hyperglycemia-Pt has known elevated FS in setting of steroids
   - cont ISS
   .
   # PPX: PPI, Coumadin
   # ACCESS: Left EJ, PIV
   # CODE:FULL
   # CONTACT: [**Name (NI) 430**] [**Name (NI) 8128**], sister [**Telephone/Fax (1) 10948**]
   # DISPO: pending above
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   18 Gauge - [**2150-1-13**] 08:08 AM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the patient's progress note, the following conditions and potential medical complications can arise:

1. Atrial Fibrillation (AFib): The patient has developed AFib with rapid rate, which can lead to:
	* Hemodynamic instability
	* Increased risk of stroke
	* Potential for cardiac arrhythmias
2. Renal Failure (ESRD): The patient has end-stage renal disease, which can lead to:
	* Fluid overload
	* Electrolyte imbalances
	* Anemia
	* Increased risk of infection
3. Sepsis: The patient has been diagnosed with sepsis, which can lead to:
	* Multi-organ dysfunction
	* Septic shock
	* Increased risk of death
4. Neutropenia: The patient has developed neutropenia, which can lead to:
	* Increased risk of infection
	* Delayed healing
	* Potential for sepsis
5. Deep Venous Thrombosis (DVT): The patient has a known DVT, which can lead to:
	* Pulmonary embolism
	* Post-thrombotic syndrome
	* Increased risk of recurrent DVT
6. Systemic Lupus Erythematosus (SLE): The patient has a history of SLE, which can lead to:
	* Flare-ups of SLE
	* Increased risk of infection
	* Potential for organ damage
7. Hyperglycemia: The patient has hyperglycemia, which can lead to:
	* Dehydration
	* Increased risk of infection
	* Potential for diabetic ketoacidosis
8. Anemia: The patient has anemia, which can lead to:
	* Fatigue
	* Shortness of breath
	* Increased risk of infection

Potential medical complications that can arise from the patient's conditions include:

1. Cardiac arrhythmias
2. Respiratory failure
3. Renal failure
4. Sepsis
5. Infection
6. Pulmonary embolism
7. Post-thrombotic syndrome
8. Flare-ups of SLE
9. Diabetic ketoacidosis
10. Organ damage

The patient's care plan should focus on managing these conditions and preventing potential complications. This may include adjusting medications, monitoring vital signs, and providing supportive care."
151778.0,205979,2150-01-14 10:36:00,Physician ,Physician Attending Progress Note,"Chief Complaint: Afib with RVR
   I saw and examined the patient, and was physically present with the ICU
   Resident for key portions of the services provided.  I agree with his /
   her note above, including assessment and plan.
   24 Hour Events:
   Recurrent Afib with RVR overnight after HD. received digoxin po and
   rate improved to the 100. Vanco and meropenem d/c'd per ID. HR
   Allergies:
   Bactrim Ds (Oral) (Sulfamethoxazole/Trimethoprim)
   Exfoliative [**Doctor Last Name **]
   Cellcept (Oral) (Mycophenolate Mofetil)
   Rash;
   Zosyn (Intraven) (Piperacillin Sodium/Tazobactam)
   Myelosuppressio
   Last dose of Antibiotics:
   Vancomycin - [**2150-1-12**] 06:29 AM
   Meropenem - [**2150-1-12**] 12:28 PM
   Infusions:
   Other ICU medications:
   Other medications:
   dapsone, daptomycin 300 iv q48, prednisone 5mg daily, warfarin 2.5
   [**Last Name (LF) 11009**], [**First Name3 (LF) **], midodrine, nephrocaps, omeprazole, insulin, digoxin.
   Changes to medical and family history:
   PMH, SH, FH and ROS are unchanged from Admission except where noted
   above and below
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2150-1-14**] 10:35 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**51**] AM
   Tmax: 36.9
C (98.4
   Tcurrent: 36.8
C (98.2
   HR: 100 (71 - 121) bpm
   BP: 95/61(67) {88/52(62) - 113/75(177)} mmHg
   RR: 15 (15 - 24) insp/min
   SpO2: 97%
   Heart rhythm: AF (Atrial Fibrillation)
             Total In:
                                                                    161 mL
                                                                    103 mL
   PO:
             TF:
   IVF:
                                                                    161 mL
                                                                    103 mL
   Blood products:
   Total out:
                                                                      0 mL
                                                                      0 mL
   Urine:
   NG:
   Stool:
   Drains:
   Balance:
                                                                    161 mL
                                                                    103 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 97%
   ABG: ///30/
   Physical Examination
   General Appearance: Well nourished, No acute distress
   Head, Ears, Nose, Throat: Normocephalic
   Cardiovascular: (S1: Normal), (S2: Normal), tachy, irregular
   Peripheral Vascular: (Right radial pulse: Present), (Left radial pulse:
   Present), (Right DP pulse: Present), (Left DP pulse: Present)
   Respiratory / Chest: (Breath Sounds: Clear : )
   Abdominal: Soft, Non-tender, Bowel sounds present
   Extremities: Right lower extremity edema: Absent, Left lower extremity
   edema: Absent
   Skin:  Warm
   Neurologic: Attentive, Follows simple commands, Responds to: Verbal
   stimuli, Movement: Purposeful, Tone: Normal
   Labs / Radiology
   7.3 g/dL
   91 K/uL
   81 mg/dL
   2.5 mg/dL
   30 mEq/L
   3.4 mEq/L
   10 mg/dL
   106 mEq/L
   143 mEq/L
   22.4 %
   2.2 K/uL
        [image002.jpg]
                             [**2150-1-10**]  11:24 PM
                             [**2150-1-11**]  05:41 AM
                             [**2150-1-11**]  03:29 PM
                             [**2150-1-12**]  05:03 AM
                             [**2150-1-12**]  03:39 PM
                             [**2150-1-13**]  07:47 AM
                             [**2150-1-13**]  11:37 AM
                             [**2150-1-13**]  05:23 PM
                             [**2150-1-14**]  04:22 AM
   WBC
   2.9
   2.8
   3.5
   2.3
   2.6
   2.8
   2.2
   Hct
   20.6
   23.1
   27.4
   25.3
   28.0
   25.2
   22.4
   Plt
   65
   60
   96
   76
   90
   92
   91
   Cr
   3.0
   3.1
   4.2
   4.4
   4.5
   2.5
   TropT
   0.02
   0.02
   0.08
   0.06
   Glucose
   119
   74
   77
   126
   84
   81
   Other labs: PT / PTT / INR:34.9/31.8/3.6, CK / CKMB /
   Troponin-T:10//0.06, Alk Phos / T Bili:/0.4, Differential-Neuts:26.0 %,
   Band:4.0 %, Lymph:62.0 %, Mono:5.0 %, Eos:2.0 %, Lactic Acid:1.4
   mmol/L, LDH:443 IU/L, Ca++:7.8 mg/dL, Mg++:1.6 mg/dL, PO4:2.1 mg/dL
   Assessment and Plan
   ATRIAL FIBRILLATION (AFIB): continues on dig but remains in the
   100-110, BP stable.
   VRE bacteremia: on daptomycin alone
   Fever: has been afebrile since admission
   AV graft clot: hold coumadin x1d as INR supratherapeutic today, then
   resume tomorrow at lower dose.
   CMV viremia: off valgancylovir.. will follow up PCR test.
   Hct drop: guaiac her stool, ? residual effect of linezold, and
   gancyclovir, likely [**12-30**] to marrow suppression.
   SLE: continue prednisone 5mg daily.
   ICU Care
   Nutrition: regular diet
   Glycemic Control:
   Lines:
   18 Gauge - [**2150-1-13**] 08:08 AM
   Prophylaxis:
   DVT: Boots
   Stress ulcer: PPI
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition :Transfer to floor
   Total time spent: 40 minutes
   ------ Protected Section ------
   I saw and examined the pt, and was physically present w/the ICU team
   for the key portions of services provided. I agree with Dr. [**First Name (STitle) 8379**]
   note, including assessment and plan. 52 yo female with SLE, ESRD failed
   transplant on HD, recent hospitalization for VRE bacteremia.
   Re-developed fevers during this hospitalization. Re-admitted to ICU for
   rapid afib with hypotension. Initially converted to SR, but back in
   afib yesterday following HD
   Plans;
   1.       Afib- management discussed with renal team again. BP remains
   the major factor barring our ability to achieve appropriate rate
   control, due to concerns that beta-blockers will leave no BP room for
   effective diuresis. Pt received digoxin load earlier today, remains
   mildly tachycardic with HR
s hovering 100-120
s. [**Month (only) 11**] need to
   re-consider beta blocker at lower dose, vs. amiodarone
   2.       Fvers: afebrile, on daptomycin. Gancyclovir stopped upon
   hospital admission due to concerns abt this inducing pancytopenia. Will
   talk to ID team regarding whether alternate prophylaxis warranted
   3.       SLE: on prednisone chronically
   4.       CKD: on HD, renal team following
   Remains in ICU until afib/tachycardia adequately controlled
   Total time spent: 34 minutes.
   ------ Protected Section Addendum Entered By:[**Name (NI) 341**] [**Last Name (NamePattern1) **], MD
   on:[**2150-1-14**] 15:59 ------
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint: Afib with RVR
   I saw and examined the patient, and was physically present with the ICU
   Resident for key portions of the services provided.  I agree with his /
   her note above, including assessment and plan.
   24 Hour Events:
   Recurrent Afib with RVR overnight after HD. received digoxin po and
   rate improved to the 100. Vanco and meropenem d/c'd per ID. HR
   Allergies:
   Bactrim Ds (Oral) (Sulfamethoxazole/Trimethoprim)
   Exfoliative [**Doctor Last Name **]
   Cellcept (Oral) (Mycophenolate Mofetil)
   Rash;
   Zosyn (Intraven) (Piperacillin Sodium/Tazobactam)
   Myelosuppressio
   Last dose of Antibiotics:
   Vancomycin - [**2150-1-12**] 06:29 AM
   Meropenem - [**2150-1-12**] 12:28 PM
   Infusions:
   Other ICU medications:
   Other medications:
   dapsone, daptomycin 300 iv q48, prednisone 5mg daily, warfarin 2.5
   [**Last Name (LF) 11009**], [**First Name3 (LF) **], midodrine, nephrocaps, omeprazole, insulin, digoxin.
   Changes to medical and family history:
   PMH, SH, FH and ROS are unchanged from Admission except where noted
   above and below
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2150-1-14**] 10:35 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**51**] AM
   Tmax: 36.9
C (98.4
   Tcurrent: 36.8
C (98.2
   HR: 100 (71 - 121) bpm
   BP: 95/61(67) {88/52(62) - 113/75(177)} mmHg
   RR: 15 (15 - 24) insp/min
   SpO2: 97%
   Heart rhythm: AF (Atrial Fibrillation)
             Total In:
                                                                    161 mL
                                                                    103 mL
   PO:
             TF:
   IVF:
                                                                    161 mL
                                                                    103 mL
   Blood products:
   Total out:
                                                                      0 mL
                                                                      0 mL
   Urine:
   NG:
   Stool:
   Drains:
   Balance:
                                                                    161 mL
                                                                    103 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 97%
   ABG: ///30/
   Physical Examination
   General Appearance: Well nourished, No acute distress
   Head, Ears, Nose, Throat: Normocephalic
   Cardiovascular: (S1: Normal), (S2: Normal), tachy, irregular
   Peripheral Vascular: (Right radial pulse: Present), (Left radial pulse:
   Present), (Right DP pulse: Present), (Left DP pulse: Present)
   Respiratory / Chest: (Breath Sounds: Clear : )
   Abdominal: Soft, Non-tender, Bowel sounds present
   Extremities: Right lower extremity edema: Absent, Left lower extremity
   edema: Absent
   Skin:  Warm
   Neurologic: Attentive, Follows simple commands, Responds to: Verbal
   stimuli, Movement: Purposeful, Tone: Normal
   Labs / Radiology
   7.3 g/dL
   91 K/uL
   81 mg/dL
   2.5 mg/dL
   30 mEq/L
   3.4 mEq/L
   10 mg/dL
   106 mEq/L
   143 mEq/L
   22.4 %
   2.2 K/uL
        [image002.jpg]
                             [**2150-1-10**]  11:24 PM
                             [**2150-1-11**]  05:41 AM
                             [**2150-1-11**]  03:29 PM
                             [**2150-1-12**]  05:03 AM
                             [**2150-1-12**]  03:39 PM
                             [**2150-1-13**]  07:47 AM
                             [**2150-1-13**]  11:37 AM
                             [**2150-1-13**]  05:23 PM
                             [**2150-1-14**]  04:22 AM
   WBC
   2.9
   2.8
   3.5
   2.3
   2.6
   2.8
   2.2
   Hct
   20.6
   23.1
   27.4
   25.3
   28.0
   25.2
   22.4
   Plt
   65
   60
   96
   76
   90
   92
   91
   Cr
   3.0
   3.1
   4.2
   4.4
   4.5
   2.5
   TropT
   0.02
   0.02
   0.08
   0.06
   Glucose
   119
   74
   77
   126
   84
   81
   Other labs: PT / PTT / INR:34.9/31.8/3.6, CK / CKMB /
   Troponin-T:10//0.06, Alk Phos / T Bili:/0.4, Differential-Neuts:26.0 %,
   Band:4.0 %, Lymph:62.0 %, Mono:5.0 %, Eos:2.0 %, Lactic Acid:1.4
   mmol/L, LDH:443 IU/L, Ca++:7.8 mg/dL, Mg++:1.6 mg/dL, PO4:2.1 mg/dL
   Assessment and Plan
   ATRIAL FIBRILLATION (AFIB): continues on dig but remains in the
   100-110, BP stable.
   VRE bacteremia: on daptomycin alone
   Fever: has been afebrile since admission
   AV graft clot: hold coumadin x1d as INR supratherapeutic today, then
   resume tomorrow at lower dose.
   CMV viremia: off valgancylovir.. will follow up PCR test.
   Hct drop: guaiac her stool, ? residual effect of linezold, and
   gancyclovir, likely [**12-30**] to marrow suppression.
   SLE: continue prednisone 5mg daily.
   ICU Care
   Nutrition: regular diet
   Glycemic Control:
   Lines:
   18 Gauge - [**2150-1-13**] 08:08 AM
   Prophylaxis:
   DVT: Boots
   Stress ulcer: PPI
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition :Transfer to floor
   Total time spent: 40 minutes
   ------ Protected Section ------
   I saw and examined the pt, and was physically present w/the ICU team
   for the key portions of services provided. I agree with Dr. [**First Name (STitle) 8379**]
   note, including assessment and plan. 52 yo female with SLE, ESRD failed
   transplant on HD, recent hospitalization for VRE bacteremia.
   Re-developed fevers during this hospitalization. Re-admitted to ICU for
   rapid afib with hypotension. Initially converted to SR, but back in
   afib yesterday following HD
   Plans;
   1.       Afib- management discussed with renal team again. BP remains
   the major factor barring our ability to achieve appropriate rate
   control, due to concerns that beta-blockers will leave no BP room for
   effective diuresis. Pt received digoxin load earlier today, remains
   mildly tachycardic with HR
s hovering 100-120
s. [**Month (only) 11**] need to
   re-consider beta blocker at lower dose, vs. amiodarone
   2.       Fvers: afebrile, on daptomycin. Gancyclovir stopped upon
   hospital admission due to concerns abt this inducing pancytopenia. Will
   talk to ID team regarding whether alternate prophylaxis warranted
   3.       SLE: on prednisone chronically
   4.       CKD: on HD, renal team following
   Remains in ICU until afib/tachycardia adequately controlled
   Total time spent: 34 minutes.
   ------ Protected Section Addendum Entered By:[**Name (NI) 341**] [**Last Name (NamePattern1) **], MD
   on:[**2150-1-14**] 15:59 ------<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Summary:

The patient is a 52-year-old female with SLE, ESRD, and a failed kidney transplant on hemodialysis (HD). She was readmitted to the ICU for rapid atrial fibrillation (AFib) with hypotension after developing fevers during her current hospitalization. The patient's AFib was initially converted to sinus rhythm (SR) but recurred after HD. She is currently receiving digoxin and daptomycin for rate control and VRE bacteremia management, respectively.

The patient's vital signs are stable, with a heart rate of 100-120 bpm, blood pressure of 95/61 mmHg, and oxygen saturation of 97%. Her respiratory support is minimal, with no oxygen therapy or mechanical ventilation. Her physical examination is normal, with no acute distress, and her neurological examination is intact.

The patient's laboratory results show a hemoglobin level of 7.3 g/dL, white blood cell count of 2.9 K/uL, and platelet count of 65 K/uL. Her renal function is impaired, with a creatinine level of 3.0 mg/dL and a blood urea nitrogen (BUN) level of 30 mEq/L. Her electrolyte levels are within normal limits, except for a slightly elevated potassium level.

Potential Medical Complications:

1. Continued AFib: The patient's AFib may persist or recur, potentially leading to hemodynamic instability, cardiac arrhythmias, or stroke.
2. VRE Bacteremia: The patient's VRE bacteremia may progress or develop resistance to treatment, potentially leading to sepsis, organ failure, or death.
3. CKD: The patient's CKD may worsen due to the underlying disease process, potentially leading to end-stage renal disease (ESRD) or the need for dialysis.
4. SLE Flare: The patient's SLE may flare up, potentially leading to multisystem organ involvement, including kidney, lung, or skin involvement.
5. Anemia: The patient's anemia may worsen due to the underlying disease process or treatment-related factors, potentially leading to fatigue, weakness, or decreased quality of life.
6. Infection: The patient may develop infections, potentially related to her underlying disease process, treatment, or hospitalization, which could lead to sepsis, organ failure, or death.
7. Gastrointestinal Bleeding: The patient may develop gastrointestinal bleeding due to her underlying disease process, treatment, or hospitalization, which could lead to anemia, hemorrhage, or death."
151778.0,205979,2150-01-14 10:36:00,Physician ,Physician Attending Progress Note,"Chief Complaint: Afib with RVR
   I saw and examined the patient, and was physically present with the ICU
   Resident for key portions of the services provided.  I agree with his /
   her note above, including assessment and plan.
   24 Hour Events:
   Recurrent Afib with RVR overnight after HD. received digoxin po and
   rate improved to the 100. Vanco and meropenem d/c'd per ID. HR
   Allergies:
   Bactrim Ds (Oral) (Sulfamethoxazole/Trimethoprim)
   Exfoliative [**Doctor Last Name **]
   Cellcept (Oral) (Mycophenolate Mofetil)
   Rash;
   Zosyn (Intraven) (Piperacillin Sodium/Tazobactam)
   Myelosuppressio
   Last dose of Antibiotics:
   Vancomycin - [**2150-1-12**] 06:29 AM
   Meropenem - [**2150-1-12**] 12:28 PM
   Infusions:
   Other ICU medications:
   Other medications:
   dapsone, daptomycin 300 iv q48, prednisone 5mg daily, warfarin 2.5
   [**Last Name (LF) 11009**], [**First Name3 (LF) **], midodrine, nephrocaps, omeprazole, insulin, digoxin.
   Changes to medical and family history:
   PMH, SH, FH and ROS are unchanged from Admission except where noted
   above and below
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2150-1-14**] 10:35 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**51**] AM
   Tmax: 36.9
C (98.4
   Tcurrent: 36.8
C (98.2
   HR: 100 (71 - 121) bpm
   BP: 95/61(67) {88/52(62) - 113/75(177)} mmHg
   RR: 15 (15 - 24) insp/min
   SpO2: 97%
   Heart rhythm: AF (Atrial Fibrillation)
             Total In:
                                                                    161 mL
                                                                    103 mL
   PO:
             TF:
   IVF:
                                                                    161 mL
                                                                    103 mL
   Blood products:
   Total out:
                                                                      0 mL
                                                                      0 mL
   Urine:
   NG:
   Stool:
   Drains:
   Balance:
                                                                    161 mL
                                                                    103 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 97%
   ABG: ///30/
   Physical Examination
   General Appearance: Well nourished, No acute distress
   Head, Ears, Nose, Throat: Normocephalic
   Cardiovascular: (S1: Normal), (S2: Normal), tachy, irregular
   Peripheral Vascular: (Right radial pulse: Present), (Left radial pulse:
   Present), (Right DP pulse: Present), (Left DP pulse: Present)
   Respiratory / Chest: (Breath Sounds: Clear : )
   Abdominal: Soft, Non-tender, Bowel sounds present
   Extremities: Right lower extremity edema: Absent, Left lower extremity
   edema: Absent
   Skin:  Warm
   Neurologic: Attentive, Follows simple commands, Responds to: Verbal
   stimuli, Movement: Purposeful, Tone: Normal
   Labs / Radiology
   7.3 g/dL
   91 K/uL
   81 mg/dL
   2.5 mg/dL
   30 mEq/L
   3.4 mEq/L
   10 mg/dL
   106 mEq/L
   143 mEq/L
   22.4 %
   2.2 K/uL
        [image002.jpg]
                             [**2150-1-10**]  11:24 PM
                             [**2150-1-11**]  05:41 AM
                             [**2150-1-11**]  03:29 PM
                             [**2150-1-12**]  05:03 AM
                             [**2150-1-12**]  03:39 PM
                             [**2150-1-13**]  07:47 AM
                             [**2150-1-13**]  11:37 AM
                             [**2150-1-13**]  05:23 PM
                             [**2150-1-14**]  04:22 AM
   WBC
   2.9
   2.8
   3.5
   2.3
   2.6
   2.8
   2.2
   Hct
   20.6
   23.1
   27.4
   25.3
   28.0
   25.2
   22.4
   Plt
   65
   60
   96
   76
   90
   92
   91
   Cr
   3.0
   3.1
   4.2
   4.4
   4.5
   2.5
   TropT
   0.02
   0.02
   0.08
   0.06
   Glucose
   119
   74
   77
   126
   84
   81
   Other labs: PT / PTT / INR:34.9/31.8/3.6, CK / CKMB /
   Troponin-T:10//0.06, Alk Phos / T Bili:/0.4, Differential-Neuts:26.0 %,
   Band:4.0 %, Lymph:62.0 %, Mono:5.0 %, Eos:2.0 %, Lactic Acid:1.4
   mmol/L, LDH:443 IU/L, Ca++:7.8 mg/dL, Mg++:1.6 mg/dL, PO4:2.1 mg/dL
   Assessment and Plan
   ATRIAL FIBRILLATION (AFIB): continues on dig but remains in the
   100-110, BP stable.
   VRE bacteremia: on daptomycin alone
   Fever: has been afebrile since admission
   AV graft clot: hold coumadin x1d as INR supratherapeutic today, then
   resume tomorrow at lower dose.
   CMV viremia: off valgancylovir.. will follow up PCR test.
   Hct drop: guaiac her stool, ? residual effect of linezold, and
   gancyclovir, likely [**12-30**] to marrow suppression.
   SLE: continue prednisone 5mg daily.
   ICU Care
   Nutrition: regular diet
   Glycemic Control:
   Lines:
   18 Gauge - [**2150-1-13**] 08:08 AM
   Prophylaxis:
   DVT: Boots
   Stress ulcer: PPI
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition :Transfer to floor
   Total time spent: 40 minutes
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint: Afib with RVR
   I saw and examined the patient, and was physically present with the ICU
   Resident for key portions of the services provided.  I agree with his /
   her note above, including assessment and plan.
   24 Hour Events:
   Recurrent Afib with RVR overnight after HD. received digoxin po and
   rate improved to the 100. Vanco and meropenem d/c'd per ID. HR
   Allergies:
   Bactrim Ds (Oral) (Sulfamethoxazole/Trimethoprim)
   Exfoliative [**Doctor Last Name **]
   Cellcept (Oral) (Mycophenolate Mofetil)
   Rash;
   Zosyn (Intraven) (Piperacillin Sodium/Tazobactam)
   Myelosuppressio
   Last dose of Antibiotics:
   Vancomycin - [**2150-1-12**] 06:29 AM
   Meropenem - [**2150-1-12**] 12:28 PM
   Infusions:
   Other ICU medications:
   Other medications:
   dapsone, daptomycin 300 iv q48, prednisone 5mg daily, warfarin 2.5
   [**Last Name (LF) 11009**], [**First Name3 (LF) **], midodrine, nephrocaps, omeprazole, insulin, digoxin.
   Changes to medical and family history:
   PMH, SH, FH and ROS are unchanged from Admission except where noted
   above and below
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2150-1-14**] 10:35 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**51**] AM
   Tmax: 36.9
C (98.4
   Tcurrent: 36.8
C (98.2
   HR: 100 (71 - 121) bpm
   BP: 95/61(67) {88/52(62) - 113/75(177)} mmHg
   RR: 15 (15 - 24) insp/min
   SpO2: 97%
   Heart rhythm: AF (Atrial Fibrillation)
             Total In:
                                                                    161 mL
                                                                    103 mL
   PO:
             TF:
   IVF:
                                                                    161 mL
                                                                    103 mL
   Blood products:
   Total out:
                                                                      0 mL
                                                                      0 mL
   Urine:
   NG:
   Stool:
   Drains:
   Balance:
                                                                    161 mL
                                                                    103 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 97%
   ABG: ///30/
   Physical Examination
   General Appearance: Well nourished, No acute distress
   Head, Ears, Nose, Throat: Normocephalic
   Cardiovascular: (S1: Normal), (S2: Normal), tachy, irregular
   Peripheral Vascular: (Right radial pulse: Present), (Left radial pulse:
   Present), (Right DP pulse: Present), (Left DP pulse: Present)
   Respiratory / Chest: (Breath Sounds: Clear : )
   Abdominal: Soft, Non-tender, Bowel sounds present
   Extremities: Right lower extremity edema: Absent, Left lower extremity
   edema: Absent
   Skin:  Warm
   Neurologic: Attentive, Follows simple commands, Responds to: Verbal
   stimuli, Movement: Purposeful, Tone: Normal
   Labs / Radiology
   7.3 g/dL
   91 K/uL
   81 mg/dL
   2.5 mg/dL
   30 mEq/L
   3.4 mEq/L
   10 mg/dL
   106 mEq/L
   143 mEq/L
   22.4 %
   2.2 K/uL
        [image002.jpg]
                             [**2150-1-10**]  11:24 PM
                             [**2150-1-11**]  05:41 AM
                             [**2150-1-11**]  03:29 PM
                             [**2150-1-12**]  05:03 AM
                             [**2150-1-12**]  03:39 PM
                             [**2150-1-13**]  07:47 AM
                             [**2150-1-13**]  11:37 AM
                             [**2150-1-13**]  05:23 PM
                             [**2150-1-14**]  04:22 AM
   WBC
   2.9
   2.8
   3.5
   2.3
   2.6
   2.8
   2.2
   Hct
   20.6
   23.1
   27.4
   25.3
   28.0
   25.2
   22.4
   Plt
   65
   60
   96
   76
   90
   92
   91
   Cr
   3.0
   3.1
   4.2
   4.4
   4.5
   2.5
   TropT
   0.02
   0.02
   0.08
   0.06
   Glucose
   119
   74
   77
   126
   84
   81
   Other labs: PT / PTT / INR:34.9/31.8/3.6, CK / CKMB /
   Troponin-T:10//0.06, Alk Phos / T Bili:/0.4, Differential-Neuts:26.0 %,
   Band:4.0 %, Lymph:62.0 %, Mono:5.0 %, Eos:2.0 %, Lactic Acid:1.4
   mmol/L, LDH:443 IU/L, Ca++:7.8 mg/dL, Mg++:1.6 mg/dL, PO4:2.1 mg/dL
   Assessment and Plan
   ATRIAL FIBRILLATION (AFIB): continues on dig but remains in the
   100-110, BP stable.
   VRE bacteremia: on daptomycin alone
   Fever: has been afebrile since admission
   AV graft clot: hold coumadin x1d as INR supratherapeutic today, then
   resume tomorrow at lower dose.
   CMV viremia: off valgancylovir.. will follow up PCR test.
   Hct drop: guaiac her stool, ? residual effect of linezold, and
   gancyclovir, likely [**12-30**] to marrow suppression.
   SLE: continue prednisone 5mg daily.
   ICU Care
   Nutrition: regular diet
   Glycemic Control:
   Lines:
   18 Gauge - [**2150-1-13**] 08:08 AM
   Prophylaxis:
   DVT: Boots
   Stress ulcer: PPI
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition :Transfer to floor
   Total time spent: 40 minutes<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the provided progress note, the patient is a 51-year-old individual admitted to the ICU with atrial fibrillation with rapid ventricular response (AFib with RVR). The patient's vital signs are stable, with a heart rate of 100 beats per minute (bpm) and blood pressure of 95/61 mmHg. The patient's respiratory status is stable, with a respiratory rate of 15 inspirations per minute (insp/min) and oxygen saturation of 97%.

The patient's laboratory results show a white blood cell count of 2.9-3.5 x 10^9/L, hemoglobin of 7.3-8.1 g/dL, and platelet count of 65-96 x 10^9/L. The patient's liver function tests are mildly elevated, with an alkaline phosphatase level of 443 IU/L and a lactate dehydrogenase level of 443 IU/L.

The patient has a history of bacteremia caused by vancomycin-resistant Enterococcus (VRE), and is currently being treated with daptomycin. The patient is also at risk for central venous catheter-associated bloodstream infection (CVCI) and has a central line in place.

The patient's medication list includes digoxin, daptomycin, prednisone, warfarin, midodrine, nephrocaps, omeprazole, insulin, and dapsone.

Potential medical complications that can arise from the patient's conditions include:

1. Cardiac arrhythmias: The patient's atrial fibrillation with rapid ventricular response (AFib with RVR) can lead to cardiac arrhythmias, including ventricular tachycardia or fibrillation.
2. Sepsis: The patient's bacteremia caused by VRE can lead to sepsis, which can result in organ dysfunction and even death.
3. Central venous catheter-associated bloodstream infection (CVCI): The patient's central line can become infected, leading to sepsis and potentially life-threatening complications.
4. Hematological complications: The patient's anemia and thrombocytopenia can increase the risk of bleeding and hematological complications.
5. Liver dysfunction: The patient's mildly elevated liver function tests can indicate liver dysfunction, which can lead to complications such as coagulopathy and hepatic encephalopathy.

In conclusion, the patient's condition is stable, but they are at risk for various medical complications. Close monitoring and management of the patient's condition is necessary to prevent and treat these complications."
